<SEC-DOCUMENT>0000950157-23-001138.txt : 20231114
<SEC-HEADER>0000950157-23-001138.hdr.sgml : 20231114
<ACCEPTANCE-DATETIME>20231114083103
ACCESSION NUMBER:		0000950157-23-001138
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20231113
FILED AS OF DATE:		20231114
DATE AS OF CHANGE:		20231114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AerCap Holdings N.V.
		CENTRAL INDEX KEY:			0001378789
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EQUIPMENT RENTAL & LEASING, NEC [7359]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33159
		FILM NUMBER:		231401768

	BUSINESS ADDRESS:	
		STREET 1:		AERCAP HOUSE
		STREET 2:		65 ST. STEPHEN'S GREEN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		35 31 819 2010

	MAIL ADDRESS:	
		STREET 1:		AERCAP HOUSE
		STREET 2:		65 ST. STEPHEN'S GREEN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-k.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div><br>
    </div>
    <div>
      <div style="font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
      <div style="text-align: center; font-weight: bold;">&#160;</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-weight: bold;">Washington, DC 20549</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM&#160;6-K</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="text-align: center;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z39af4f89c6714e0d92bd653f62e7601f">

          <tr>
            <td style="width: 42.48%; vertical-align: top;">
              <div style="text-indent: -10.1pt; margin-left: 10.1pt; font-weight: bold;">For the month of November 2023</div>
            </td>
            <td style="width: 3.88%; vertical-align: bottom;">
              <div style="font-family: 'Times New Roman', serif; font-size: 1pt; font-weight: bold;">&#160;</div>
            </td>
            <td style="width: 53.64%; vertical-align: top; text-align: right; font-weight: bold;">
              <div>Commission File Number 001-33159</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">AERCAP HOLDINGS N.V.</div>
      <div style="text-align: center;">(Translation of Registrant&#8217;s Name into English)</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-weight: bold;">AerCap House, 65 St. Stephen&#8217;s Green, Dublin D02 YX20, Ireland, +353 1 819 2010</div>
      <div style="text-align: center;">(Address of Principal Executive Office)</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-indent: 21.6pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form&#160;20-F or Form&#160;40-F.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcc577a41e4cd4c009ab3c6e71097c228">

          <tr>
            <td style="width: 26.66%; vertical-align: top;">
              <div style="text-indent: -10pt; margin-left: 82pt;">Form&#160;20-F &#9746;</div>
            </td>
            <td style="width: 14.46%; vertical-align: bottom;">
              <div style="font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
            </td>
            <td style="width: 58.88%; vertical-align: top;">
              <div>Form&#160;40-F &#9744;</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-indent: 21.6pt;">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation S-T Rule&#160;101(b)(1): &#9744;</div>
      <div>&#160;</div>
      <div style="text-indent: 21.6pt;"><font style="font-weight: bold;">Note</font>:&#160; Regulation S-T Rule&#160;101(b)(1)&#160;only permits the submission in paper of a Form&#160;6-K if submitted solely to provide an attached annual report to security holders.</div>
      <div>&#160;</div>
      <div style="text-indent: 21.6pt;">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation S-T Rule&#160;101(b)(7)&#160;): &#9744;</div>
      <div>&#160;</div>
      <div style="text-indent: 21.6pt;"><font style="font-weight: bold;">Note</font>: Regulation S-T Rule&#160;101(b)(7)&#160;only permits the submission in paper of a Form&#160;6-K if submitted to furnish a report or other document that the registrant foreign private
        issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#8217;s &#8220;home country&#8221;), or under the rules&#160;of the home country exchange on which the
        registrant&#8217;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#8217;s security holders, and, if discussing a material event, has already been the
        subject of a Form&#160;6-K submission or other Commission filing on EDGAR.</div>
      <div>&#160;
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="font-weight: bold;">Other Events</div>
      <div><br>
      </div>
      <div>On November 13 and November 14, 2023, AerCap Holdings N.V. (the &#8220;Company&#8221;) announced the launch and pricing, respectively, of an underwritten secondary offering (the &#8220;Secondary Offering&#8221;) of 26,721,633 of its ordinary shares by GE Capital US
        Holdings, Inc. (the &#8220;Selling Shareholder&#8221;) at a price to the public of $65.25 per ordinary share.</div>
      <div><br>
      </div>
      <div>In connection with the Secondary Offering, the Company entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with the Selling Shareholder and Goldman Sachs &amp; Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities
        Inc., BNP Paribas Securities Corp., BofA Securities, Inc. and J.P. Morgan Securities LLC as representatives of the several underwriters named therein. Pursuant to the Underwriting Agreement, the underwriters have an option to purchase up to an
        additional 4,008,245 ordinary shares from the Selling Shareholder within 30 days from the date of the final prospectus supplement relating to the Secondary Offering (the &#8220;Option&#8221;). If the underwriters exercise the Option in full, General Electric
        Company will cease to beneficially own any of the Company&#8217;s ordinary shares. The above description of the Underwriting Agreement is qualified by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1 and is
        incorporated herein by reference.</div>
      <div><br>
      </div>
      <div>Also pursuant to the Underwriting Agreement, the Company agreed to purchase from the underwriters 7,859,163 of its ordinary shares at a price per ordinary share equal to $63.62.</div>
      <div><br>
      </div>
      <div style="color: #000000;">The information contained in this Form 6-K is incorporated by reference into the Company&#8217;s Registration Statements on Form F-3, File Nos. 333-270326 and 333-260359, Registration Statements on Form S-8, File Nos.
        333-194638, 333-194637, 333-180323, 333-165839, and 333-154416, and related Prospectuses, as such Registration Statements and Prospectuses may be amended from time to time.</div>
      <div><br>
      </div>
      <div style="font-weight: bold;">Exhibits</div>
      <div style="font-weight: bold;"> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zabac3dc71ac841f79a589aaa6ab2ce26">

            <tr>
              <td style="width: 5%; vertical-align: top;">
                <div>1.1</div>
              </td>
              <td style="width: 95%; vertical-align: top;">
                <div>Underwriting Agreement, dated November 13, 2023, by and among AerCap Holdings N.V., GE Capital US Holdings, Inc., Goldman Sachs &amp; Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., BNP Paribas Securities Corp.,
                  BofA Securities, Inc. and J.P. Morgan Securities LLC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top;">
                <div>99.1</div>
              </td>
              <td style="width: 95%; vertical-align: top;">
                <div>AerCap Holdings N.V. Press Release</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; vertical-align: top;">
                <div>99.2</div>
              </td>
              <td style="width: 95%; vertical-align: top;">
                <div>AerCap Holdings N.V. Press Release</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center;">SIGNATURE</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-indent: 36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center;">
        <div>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" id="z5d10ef85b2604942a1b9baed51fc20c2" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                <td style="vertical-align: top;" colspan="4">
                  <div style="font-family: 'Times New Roman';">AERCAP HOLDINGS N.V. </div>
                </td>
              </tr>
              <tr>
                <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                <td style="vertical-align: top;" colspan="4">&#160;</td>
              </tr>
              <tr>
                <td style="width: 44.37%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman';"><br>
                  </div>
                </td>
                <td style="width: 3.36%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman';">By:</div>
                </td>
                <td style="vertical-align: top;" colspan="2">
                  <div style="font-family: 'Times New Roman';">/s/ Aengus Kelly </div>
                </td>
                <td style="width: 13.34%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                <td style="width: 4.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman';">Name:</div>
                </td>
                <td style="width: 34.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman';">Aengus Kelly </div>
                </td>
                <td style="width: 13.34%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                <td style="width: 4.45%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman';">Title:</div>
                </td>
                <td style="width: 34.39%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman';">Authorized Signatory </div>
                </td>
                <td style="width: 13.34%; vertical-align: top;">&#160;</td>
              </tr>

          </table>
          <div style="text-align: left;"><br>
          </div>
          <div style="text-align: left;">Date: November 14, 2023 </div>
        </div>
      </div>
      <div style="text-align: center;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div style="text-align: center;">&#160;</div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT&#160;INDEX</div>
      <div style="text-align: center;">&#160;</div>
      <br>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zabac3dc71ac841f79a589aaa6ab2ce26">

          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div><a href="ex1-1.htm">1.1</a></div>
            </td>
            <td style="width: 95%; vertical-align: top;">
              <div><a href="ex1-1.htm">Underwriting Agreement, dated November 13, 2023, by and among AerCap Holdings N.V., GE Capital US Holdings, Inc., Goldman Sachs &amp; Co.
                  LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., BNP Paribas Securities Corp., BofA Securities, Inc. and J.P. Morgan Securities LLC.</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div><a href="ex99-1.htm">99.1</a></div>
            </td>
            <td style="width: 95%; vertical-align: top;">
              <div><a href="ex99-1.htm">AerCap Holdings N.V. Press Release</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top;">
              <div><a href="ex99-2.htm">99.2</a></div>
            </td>
            <td style="width: 95%; vertical-align: top;">
              <div><a href="ex99-2.htm">AerCap Holdings N.V. Press Release</a></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<DESCRIPTION>UNDERWRITING AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 1.1</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div><br>
    <div style="text-align: center; color: #000000;"><font style="font-weight: bold;">26,721,633 ORDINARY SHARES, PAR VALUE &#8364;0.01</font>&#160;<font style="font-weight: bold;">PER SHARE</font></div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">AERCAP HOLDINGS N.V.</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">UNDERWRITING AGREEMENT</div>
    <div><br>
    </div>
    <div style="text-align: right; color: #000000;">November 13, 2023</div>
    <div><br>
    </div>
    <div style="color: #000000;">Goldman Sachs &amp; Co. LLC</div>
    <div style="color: #000000;">200 West Street</div>
    <div style="color: #000000;">New York, New York 10282</div>
    <div><br>
    </div>
    <div style="color: #000000;">Citigroup Global Markets Inc.</div>
    <div style="color: #000000;">388 Greenwich Street</div>
    <div style="color: #000000;">New York, New York 10013</div>
    <div style="color: #000000;"><br>
      Deutsche Bank Securities Inc.</div>
    <div style="color: #000000;">1 Columbus Circle<br>
    </div>
    <div style="color: #000000;">New York, New York 10019</div>
    <div style="color: #000000;"> <br>
    </div>
    <div style="color: #000000;">BNP Paribas Securities Corp.<br>
    </div>
    <div style="color: #000000;">
      <div>787 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Avenue</div>
    </div>
    <div style="color: #000000;">New York, New York 10019<br>
      <br>
      BofA Securities, Inc.<br>
      One Bryant Park<br>
      New York, New York 10036<br>
      <br>
      J.P. Morgan Securities LLC<br>
      383 Madison Avenue<br>
      New York, New York 10179<br>
      <br>
    </div>
    <div style="color: #000000;">As Representatives of the</div>
    <div style="text-indent: 36pt; color: #000000;">several Underwriters listed</div>
    <div style="text-indent: 36pt; color: #000000;">in Schedule I hereto</div>
    <div><br>
    </div>
    <div>Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Introductory</u>.&#160; On the date hereof, GE Capital US Holdings, Inc., a Delaware corporation (the &#8220;<u>Selling Shareholder</u>&#8221;), proposes to sell to
      the several underwriters listed in Schedule I hereto (the &#8220;<u>Underwriters</u>&#8221;), for whom you are acting as representatives (the &#8220;<u>Representatives</u>&#8221;), an aggregate of <font style="color: #000000;">26,721,633</font> ordinary shares (the &#8220;<u>Underwritten






        Shares</u>&#8221;), par value &#8364;0.01 per share (the &#8220;<u>Ordinary Shares</u>&#8221;), of AerCap Holdings N.V., a public limited liability company (<font style="font-style: italic;">naamloze vennootschap</font>) organized under the laws of the Netherlands (the &#8220;<u>Company</u>&#8221;)







      and, at the option of the Underwriters, up to an additional <font style="color: #000000;">4,008,245</font> Ordinary Shares of the Company (the &#8220;<u>Option Shares</u>&#8221;). The Underwritten Shares and the Option Shares to be sold by the Selling
      Shareholder are herein referred to as the &#8220;<u>Securities</u>&#8221;. Subject to the sale of the Securities by the Selling Shareholder to the Underwriters in compliance with the terms of this Agreement, the Underwriters have agreed to sell to the Company,
      and the Company has agreed herein to purchase from the Underwriters (the &#8220;<u>Share Repurchase</u>&#8221;), an aggregate of 7,859,163 Ordinary Shares (the &#8220;<u>Repurchase Shares</u>&#8221;) pursuant to Section 3 of this Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representations and Warranties</u>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company represents and warrants to, and agrees with, each Underwriter that:</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company is a &#8220;foreign private issuer&#8221; as defined in Rule 405 under the Securities Act of 1933, as amended, and the rules and
      regulations of the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) promulgated thereunder (the &#8220;<u>Act</u>&#8221;) and the Company meets all of the registrant requirements of, and the transactions contemplated by this Agreement meet all of the
      transaction requirements of, and, in each case, comply with the conditions for the use of, Form F-3 under the Act. An &#8220;automatic shelf registration statement&#8221; as defined in Rule 405 under the Act, on Form F-3 (File No. 333-270326) in respect of the
      Securities, including a form of prospectus (the &#8220;<u>Base Prospectus</u>&#8221;), has been prepared and filed by the Company with the Commission not earlier than three years prior to the date hereof, which became effective upon filing under Rule 462(e)
      under the Act on March 7, 2023. For purposes of this Agreement, &#8220;<u>Effective Time</u>&#8221; with respect to such registration statement means the date and time as of which such registration statement automatically became effective upon filing thereof
      with the Commission and, if the Company has filed any post-effective amendment pursuant to Rules 413(b) and 462(e) under the Act, then &#8220;Effective Time&#8221; shall also mean the date and time as of which such post-effective amendment was or is filed with
      the Commission and, if later, declared effective by the Commission. &#8220;<u>Effective Date</u>&#8221; with respect to such registration statement means, the date of the Effective Time and, if the Company has filed a post-effective amendment to such
      registration statement pursuant to Rules 413(b) and 462(e) under the Act, then &#8220;Effective Date&#8221; shall also mean the date of the Effective Time of such post-effective amendment. Such registration statement, including exhibits and any amendments
      thereto filed prior to the Applicable Time (as defined below) deemed to be a part of the registration statement as of the Effective Time, is hereinafter referred to as the &#8220;<u>Registration Statement</u>&#8221;. If the Company has filed a post-effective
      amendment pursuant to Rules 413(b) and 462(e) under the Act, then any reference herein to the term &#8220;Registration Statement&#8221; shall be deemed to include such post-effective amendment. As used herein, the term &#8220;<u>Prospectus</u>&#8221; means the final
      prospectus relating to the Securities first filed with the Commission pursuant to and within the time limits described in Rule 424(b) under the Act and in accordance with Section 5(a)(i) hereof. The Base Prospectus, as supplemented by any preliminary
      prospectus (including any preliminary prospectus supplement) relating to the Securities filed with the Commission pursuant to Rule 424(b) under the Act, including the documents incorporated by reference in the Base Prospectus and each such
      preliminary prospectus and preliminary prospectus supplement is herein referred to as a &#8220;<u>Preliminary Prospectus</u>.&#8221; Any reference herein to the Registration Statement or any Preliminary Prospectus or to the Prospectus or to any amendment or
      supplement to any of the foregoing documents shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 6 of Form F-3 under the Act, as of the Effective Time of the Registration Statement or the date of
      such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#8220;amend,&#8221; &#8220;amendment&#8221; or supplement with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to include any
      documents incorporated by reference therein, and any supplements or amendments thereto, filed with the Commission after the date of filing of the Prospectus under Rule 424(b) under the Act, and prior to the termination of the offering of the
      Securities by the Underwriters.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of the Applicable Time (as defined below), none of (a) the Base Prospectus, the information set forth in Schedule II hereto
      and each Issuer Free Writing Prospectus listed on Schedule III hereto, all considered together (collectively, the &#8220;<u>General Disclosure Package</u>&#8221;), (b) any other &#8220;free writing prospectus&#8221; (as defined pursuant to Rule 405 under the Securities Act)
      (a &#8220;<u>Free Writing Prospectus</u>&#8221;) that the Underwriters shall hereafter expressly agree in writing to treat as part of the General Disclosure Package in accordance with Section 5(a)(ii) below, when taken together as a whole with the General
      Disclosure Package, or (c) each electronic road show, if any, when taken together as a whole with the General Disclosure Package, included any untrue statement of a material fact or omitted or will omit to state a material fact necessary to make the
      statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company makes no representations or warranties as to any Underwriter Information or Selling Shareholder Information (as
      defined in Sections 7(c) and 2(b)(i), respectively, hereof). As used in this Agreement:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">&#8220;<u>Applicable Time</u>&#8221; means 7:45 p.m. (Eastern time) on the date of this Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<u>Issuer Free Writing Prospectus</u>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 under the Act, relating to the Securities in the form filed or required
      to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g) under the Act.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: #000000;">The Commission has not issued any order preventing or suspending the use of the Registration
        Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus or relating to the proposed offering of the Securities, and no proceeding for that purpose or pursuant to Section 8A of the Act has been instituted or, to
        the Company&#8217;s knowledge, threatened by the Commission. The Registration Statement and any amendment thereto, as of each Effective Time, and the Prospectus, as then amended or supplemented, as of the Applicable Time, at the time filed with the
        Commission and as of the Closing Date or the Additional Closing Date (as defined herein), as the case may be, complied or will comply as to form in all material respects with the requirements of the Act. The documents incorporated, or to be
        incorporated, by reference in the Registration Statement and the Prospectus, at the time filed with the Commission, complied or will comply as to form in all material respects with the requirements of the Securities Exchange Act of 1934, as
        amended, and the rules and regulations of the SEC promulgated thereunder (collectively, the &#8220;<u>Exchange Act</u>&#8221;). The Registration Statement and any amendment thereto, as of each Effective Time, did not contain, and will not contain, any untrue
        statement of a material fact and did not omit, and will not omit, to </font>state<font style="color: #000000;"> a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus, as then
        amended or supplemented, as of the Applicable Time, at the time filed with the Commission and as of the Closing Date or the Additional Closing Date, as the case may be, did not contain, and will not contain, any untrue statement of a material fact,
        and did not omit, and will not omit, to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Notwithstanding anything to the contrary in this clause (iii), the
        Company makes no representations or warranties with respect to any Underwriter Information or Selling Shareholder Information.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of its date and as of the Applicable Time, each Issuer Free Writing Prospectus (i) complied and will comply with the
      requirements of the Act and (ii) did not and will not include any information that conflicted or will conflict with the information contained in the Registration Statement, the Preliminary Prospectus (if the Prospectus has not been filed with the
      Commission immediately prior to the time of first use of any such Issuer Free Writing Prospectus) or the Prospectus, in each case, as then amended or supplemented immediately prior to the date of first use of any such Issuer Free Writing Prospectus.
      Notwithstanding anything to the contrary in this clause (iv), the Company makes no representations or warranties with respect to any Underwriter Information or Selling Shareholder Information.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not, directly or
      indirectly, prepared, used, distributed, authorized, approved or referred to and will not prepare, use, distribute, authorize, approve or refer to, any offering material in connection with the offering and sale of the Securities, including, without
      limitation, any Issuer Free Writing Prospectus or other Free Writing Prospectus or &#8220;written communication&#8221; (as defined in Rule 405 under the Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities, other than any
      Preliminary Prospectus, the Prospectus, and each Free Writing Prospectus approved in writing in advance by the Representatives in accordance with Section 5(a)(ii) below (each, a &#8220;<u>Permitted Free Writing Prospectus</u>&#8221;). To the extent it is
      required to do so, the Company has filed and will file with the Commission all Issuer Free Writing Prospectuses in the time and manner required under Rules 163(b)(2) and 433(d) under the Act. The Company has retained in accordance with the Act all
      Issuer Free Writing Prospectuses that were not required to be filed pursuant to the Act.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i) At the time of filing of the Registration Statement, (ii) at the time of the most recent amendment thereto for the purposes
      of complying with Section 10(a)(3) of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of prospectus), (iii) at the time the Company or any person
      acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Act) made any offer relating to the Securities in reliance on the exemption of Rule 163 under the Act, and (iv) at the Applicable Time, the Company was and is a
      &#8220;well-known seasoned issuer&#8221; as defined in Rule 405 under the Act. The Company has not received from the Commission any notice pursuant to Rule 401(g)(2) under the Act objecting to the use of the automatic shelf registration form or any
      post-effective amendment thereto.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At the earliest time after the filing the Registration Statement that the Company or Selling Shareholder or another offering
      participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Act) of the Securities and as of the Applicable Time, the Company was not and is not an &#8220;ineligible issuer&#8221; (as defined in Rule 405 under the Act, without taking into
      account any determination by the Commission pursuant to Rule 405 under the Act that it is not necessary that the Company be considered an ineligible issuer), including, without limitation, for purposes of Rules 164 and 433 under the Act with respect
      to the offering of the Securities as contemplated by the Registration Statement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Neither the Company nor any of its subsidiaries is, or after giving effect to the offering and sale of the Securities and the
      Share Repurchase as described in the Registration Statement, the General Disclosure Package and the Prospectus will be, required to register as an &#8220;investment company&#8221; as such term is defined in the Investment Company Act.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ix)</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; The Company is not a party to any contractual arrangement currently in effect relating to the offer, sale, distribution or
      delivery of the Securities or any other securities of the Company (including with respect to granting any person registration rights or similar rights to have any securities of the Company registered for sale under the Registration Statement) other
      than this Agreement and the arrangements disclosed in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), including the registration rights granted to the
      Selling Shareholder with respect to the Securities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company has not taken, nor will it take, directly or indirectly, any action designed to or that has constituted, or that
      might reasonably be expected to cause or result, under the Exchange Act or otherwise, in stabilization or manipulation of the price of the Ordinary Shares to facilitate the sale or resale of the Securities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company has been duly incorporated and is validly existing as a public limited liability company under the laws of the
      Netherlands, with the corporate power and authority to own its property and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus, and is duly qualified to transact business in each
      jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing (where such concept exists) would not reasonably be
      expected to, singly or in the aggregate, have a material adverse effect on the condition (financial or otherwise), earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the
      ordinary course of business (a &#8220;<u>Material Adverse Effect</u>&#8221;).</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each significant subsidiary (as defined in Rule 1-02 of Regulation S-X) of the Company (a &#8220;<u>Significant Subsidiary</u>&#8221;) has
      been duly incorporated or formed, as applicable, and is validly existing as a private limited company, corporation or other legal entity in good standing (where such concept exists) under the laws of the jurisdiction of its incorporation or
      formation, with the power and authority (corporate or other) to own its property and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus, and is duly qualified to transact business and
      is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or to be in good standing would not, singly or
      in the aggregate, have a Material Adverse Effect; all of the issued shares of capital stock or other similar ownership interests of each Significant Subsidiary have been duly and validly authorized and issued, are (in jurisdictions where such
      concepts are recognized) fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims, except as described in the Registration Statement, the General Disclosure
      Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xiii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Securities and all other outstanding shares of capital stock of the Company, including the Ordinary Shares, conform to the
      description thereof in the Company&#8217;s Annual Report on Form 20-F for the year December 31, 2022, incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus. The statements in the Registration Statement,
      the General Disclosure Package and the Prospectus under the heading &#8220;Description of Ordinary Shares&#8221; and the statements incorporated by reference therein, insofar as they purport to constitute a summary of the terms of the Securities, fairly and
      accurately summarize the matters therein described in all material respects.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xiv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The statements in and incorporated by reference into (i) the Registration Statement and Base Prospectus under the heading &#8220;Tax
      Considerations&#8221; and (ii) the Prospectus under the heading &#8220;Certain Tax Considerations&#8221;, in each case, insofar as they purport to constitute summaries of tax law or legal conclusions with respect thereto, fairly and accurately summarize the matters
      therein described in all material respects.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; This Agreement has been duly authorized, executed and delivered by the Company, and the Share Repurchase has been duly authorized
      by the Company.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xvi)</font>&#160;&#160;&#160;&#160;&#160;&#160; None of the execution, delivery or performance by the Company of its obligations under this Agreement or the consummation of any
      other of the transactions herein, including the Share Repurchase, or the fulfillment of the terms hereof or thereof will contravene (i) the charter, by-laws, memorandum and articles of association or similar organizational documents of the Company or
      any of its subsidiaries, (ii) any agreement or other instrument binding upon the Company or any of its subsidiaries or (iii) any provision of applicable law or any judgment, order or decree of any governmental body, agency or court having
      jurisdiction over the Company or any of its subsidiaries, except for, in the cases of clauses (ii) and (iii) above, such contravention that would not, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xvii)</font>&#160;&#160;&#160;&#160;&#160; No consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for the
      performance by the Company of its obligations under this Agreement in connection with the sale of the Securities contemplated hereby and the Share Repurchase, except (i) such filings as may be required under the Act, (ii) such as relate to the review
      of the transactions by the Financial Industry Regulatory Authority, Inc. (&#8220;<u>FINRA</u>&#8221;), (iii) such filings as may be required under applicable state securities or blue sky laws, (iv) such filings as may be required under The New York Stock
      Exchange (the &#8220;<u>NYSE</u>&#8221;) rules or (v) such other consents, approvals, authorizations, orders or filings as have been obtained or made.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xviii)</font> &#160; &#160; The audited consolidated financial statements of the Company and its subsidiaries included or incorporated by reference in the
      Registration Statement, the General Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Act and the Exchange Act, as applicable, and present fairly in all material respects the consolidated
      financial position of the Company and its subsidiaries as of and at the dates indicated, and the results of operations and cash flows for the periods specified. Such financial statements were prepared in accordance with accounting principles
      generally accepted in the United States (&#8220;<u>U.S. GAAP</u>&#8221;), consistently applied for the periods specified by the Company to its respective financial statements, except as may be stated in the related notes thereto; and all non-GAAP financial
      information included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, if any, complies in all material respects with the requirements of Regulation G and Item 10 of Regulation S-K under
      the Act. The interactive data in extensible Business Reporting Language included or incorporated by reference in each of the Registration Statement, the General Disclosure Package and the Prospectus fairly present the information called for in all
      material respects and are prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xix)</font>&#160; &#160; &#160;&#160;&#160; There are no legal or governmental proceedings pending or, to the knowledge of the Company, threatened to which the Company or any
      of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject other than proceedings described in the Registration Statement, the General Disclosure Package and the Prospectus (in each case,
      exclusive of any amendment or supplement thereto) and proceedings that would not, singly or in the aggregate, have a Material Adverse Effect and would not have a material adverse effect on the power or ability of the Company to (x) perform its
      obligations under this Agreement or (y) consummate the Share Repurchase.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xx)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and its subsidiaries have good and marketable title to all real property and good and marketable title to all
      personal property owned by them that is material to the business of the Company and its subsidiaries, taken as a whole, in each case free and clear of all liens, encumbrances and defects, except such liens, encumbrances and defects as are described
      in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto) and to the extent the failure to have such title or the existence of such liens, encumbrances and
      defects would not, singly or in the aggregate, have a Material Adverse Effect; and any real property and buildings that are material to the Company and its subsidiaries, taken as a whole, and are held under lease by the Company or any of its
      subsidiaries are held by them under legal and valid leases with such exceptions as do not interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries, except as described in the Registration
      Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto) or as would not, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and its subsidiaries own, lease or manage, directly or indirectly, the aircraft described in the Registration
      Statement, the General Disclosure Package and the Prospectus (collectively, the &#8220;<u>Company Aircraft Portfolio</u>&#8221;). Except as described in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any
      amendment or supplement thereto) or except as would not, singly or in the aggregate, have a Material Adverse Effect, (x) with respect to owned and leased aircraft, the Company and its subsidiaries have, directly or indirectly, good and marketable
      title to or economic rights equivalent to holding good and marketable title to, or hold valid and enforceable leases in respect of, the Company Aircraft Portfolio and (y) with respect to managed aircraft, to the Company&#8217;s knowledge, the management
      contracts of the Company and its subsidiaries with the entities that own (or have the right to the economic benefits of ownership of) the Company Aircraft Portfolio are in full force and effect.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All of the lease agreements, lease addenda, side letters, assignments of warranties, option agreements or similar agreements
      material to the business of the Company and its Significant Subsidiaries, taken as a whole (collectively, the &#8220;<u>Lease Documents</u>&#8221;), are in full force and effect, except as would not, singly or in the aggregate, have a Material Adverse Effect;
      and to the Company&#8217;s knowledge, no event that with the giving of notice or passage of time or both would become an event of default (as so defined) under any Lease Document has occurred, except such event of default that would not, singly or in the
      aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxiii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and its subsidiaries have entered into aircraft purchase agreements (the &#8220;<u>Aircraft Purchase Documents</u>&#8221;) and
      letters of intent for the purchase of aircraft consistent in all material respects with the description thereof in the Registration Statement, the General Disclosure Package and the Prospectus. Except as described in the Registration Statement, the
      General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto) the Aircraft Purchase Documents are in full force and effect and no event of default (as defined in the applicable Aircraft Purchase
      Document) has occurred and is continuing under any Aircraft Purchase Document, except, in each case, for such failures and events of default that would not, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxiv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;None of the Company or any Significant Subsidiary is in violation of or default under (i) any provision of its charter or
      bylaws or comparable organizational documents; (ii) the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a party or bound
      or to which its property is subject; or (iii) any statute, law, rule, regulation, judgment, order or decree applicable to the Company or any of its subsidiaries of any court, regulatory body, administrative agency, governmental body, arbitrator or
      other authority having jurisdiction over the Company, any of its subsidiaries or of the properties of the Company or any of its subsidiaries, as applicable, except for, in the cases of clauses (ii) and (iii) above, such violations and defaults that
      would not, singly or in the aggregate, have a Material Adverse Effect. For the avoidance of doubt, when used in this Agreement the term &#8220;subsidiary&#8221; shall be limited to only those entities which are majority-owned by the Company.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;KPMG Ireland, who have audited the financial statements of the Company and its consolidated subsidiaries as of and for the years
      ended December 31, 2022 and 2021 and delivered their report with respect to the audited consolidated financial statements included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, are
      independent public accountants with respect to the Company and its consolidated subsidiaries within the meaning of the Act and the applicable published rules and regulations thereunder and the rules and regulations of the Public Company Accounting
      Oversight Board (&#8220;<u>PCAOB</u>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxvi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; [Reserved].</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxvii)</font>&#160;&#160;&#160;&#160;&#160;&#160; There are no stamp or other issuance or transfer taxes or duties or other similar fees or charges required to be paid to the
      United States, Ireland or the Netherlands or any political subdivision or taxing authority thereof in connection with (i) the execution and delivery of this Agreement, (ii) the sale or delivery of the Securities to the Underwriters, (iii) the resale
      and delivery by the Underwriters of the Securities in the manner contemplated by this Agreement or (iv) the Share Repurchase.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxviii)</font>&#160;&#160;&#160;&#160; The Company and its subsidiaries own or possess, or can acquire on reasonable terms, all patents, patent rights, licenses,
      inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks and trade names (collectively, &#8220;<u>Intellectual Property</u>&#8221;),






      necessary to carry on the business now operated by them, except as would not, singly or in the aggregate, have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of infringement of or conflict with
      asserted rights of others with respect to any Intellectual Property that would reasonably be expected to, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and its subsidiaries have filed all applicable tax returns that are required to be filed or have requested
      extensions thereof (except for any failure so to file that would not, singly or in the aggregate, have a Material Adverse Effect and except as set forth in or contemplated in the Registration Statement, the General Disclosure Package and the
      Prospectus (in each case, exclusive of any amendment or supplement thereto)) and have paid all taxes required to be paid by them and any other payment, assessment, fine or penalty levied against them, to the extent that any of the foregoing is due
      and payable, except for any such payment, assessment, fine or penalty that is currently being contested in good faith and for which appropriate reserves have been established in accordance with U.S. GAAP or as would not, singly or in the aggregate,
      have a Material Adverse Effect and except as set forth in or contemplated in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxx)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No material labor dispute with the employees of the Company or any of its subsidiaries exists, except as described in the
      Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), or, to the Company&#8217;s knowledge, is imminent; and the Company is not aware of any existing, threatened or
      imminent labor disturbance by the employees of any of their principal suppliers, manufacturers or contractors that could, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and each of its Significant Subsidiaries, and their respective owned and leased properties, are insured by insurers
      of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged, except as set forth in the Registration Statement, the General Disclosure Package and
      the Prospectus (in each case, exclusive of any amendment or supplement thereto) and for any such loss or risk that would not, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and its subsidiaries have not sustained since the date of the latest audited financial statements included or
      incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus any material loss or interference with their business by fire, explosion, flood or other calamity, whether or not covered by insurance, or from
      any court or governmental action, order or decree, except as set forth in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto) or except for any such loss or
      interference that would not, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxiii)</font>&#160;&#160;&#160;&#160;&#160; The Company and its subsidiaries possess all certificates, authorizations and permits issued by the appropriate U.S. federal or
      Dutch, Irish or other non-U.S. regulatory authorities necessary to conduct their respective businesses, except as would not, singly or in the aggregate, have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any
      notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, singly or in the aggregate, would reasonably be expected to have a Material Adverse Effect and except as described in the
      Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxiv)</font>&#160;&#160;&#160;&#160;&#160; The Company and its subsidiaries are in compliance with all applicable laws, regulations or other requirements of the United
      States Federal Aviation Administration, the European Aviation Safety Agency and similar aviation regulatory bodies (collectively, &#8220;<u>Aviation Laws</u>&#8221;), and neither the Company nor any of its subsidiaries has received any notice of a failure to
      comply with applicable Aviation Law, except for any failures to comply that would not, singly or in the aggregate, have a Material Adverse Effect.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxv)</font>&#160;&#160;&#160;&#160;&#160; The Company and each of its subsidiaries maintains a system of internal accounting controls sufficient to provide reasonable
      assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. GAAP and to maintain
      asset accountability; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and
      appropriate action is taken with respect to any differences. Since the end of the Company&#8217;s most recent audited fiscal year, there has been (i) no material weakness in the Company&#8217;s or any of the Company&#8217;s subsidiaries&#8217; internal control over
      financial reporting (whether or not remediated) and (ii) no significant change in the Company&#8217;s or any of the Company&#8217;s subsidiaries&#8217; internal control over financial reporting that has materially affected, or is reasonably likely to materially
      affect, the Company&#8217;s or any of the Company&#8217;s subsidiaries&#8217; internal control over financial reporting. The Company and its subsidiaries maintain &#8220;disclosure controls and procedures&#8221; (as defined in Rule 13a-15(e) of the Exchange Act) that are designed
      to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms,
      including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have
      carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxvi)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Company and its subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local laws and
      regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#8220;<u>Environmental Laws</u>&#8221;), (ii) have received all permits, licenses or other approvals
      required of them under applicable Environmental Laws to conduct their respective businesses, (iii) are in compliance with all terms and conditions of any such permit, license or approval and (iv) have no costs or liabilities associated with
      Environmental Laws (including, without limitation, any capital or operating expenditures by the Company or any of its subsidiaries, required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval,
      any related constraints on operating activities and any potential liabilities to third parties) for their respective accounts, except in each of clauses (i) through (iv) as would not, singly or in the aggregate, have a Material Adverse Effect and
      except as described in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxvii)</font>&#160;&#160;&#160;&#160; The operations of the Company and its subsidiaries are and have been conducted at all times in material compliance with all
      applicable financial recordkeeping and reporting requirements, including (to the extent applicable) those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the Bank Secrecy Act, as amended by Title III of the Uniting and
      Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and applicable anti-money laundering statutes of jurisdictions where the Company or any of its subsidiaries conduct
      business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;<u>Anti-Money Laundering Laws</u>&#8221;), and no action, suit or
      proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxviii)</font>&#160;&#160;&#160;&#160; Neither the Company nor any of its subsidiaries, nor, to the knowledge of the Company, any of their respective directors,
      officers, employees, agents or affiliates or anyone acting on their behalf, is currently the subject or the target of any sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control
      of the U.S. Department of the Treasury (&#8220;<u>OFAC</u>&#8221;) or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European
      Union or HM Treasury or other relevant sanctions authority (collectively, &#8220;<u>Sanctions</u>&#8221;), nor is the Company or any of its subsidiaries, except as permitted by applicable law, located, organized or resident in a country or territory that is the
      subject or target of Sanctions that broadly prohibit dealings with that country or territory (currently, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, the Kherson, the Zaporizhzhia, and the Crimea regions of
      Ukraine, Cuba, Iran, North Korea and Syria (each, a &#8220;<u>Sanctioned Country</u>&#8221;)); and, except as permitted by applicable law, the Company and its subsidiaries will not, directly or indirectly, use the proceeds of the offering of the Securities
      hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or
      facilitation, is the subject or target of any Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in the imposition of Sanctions against any person (including any
      person participating in the transactions contemplated hereby, whether as underwriter, initial purchaser, advisor, investor or otherwise). The Company and its subsidiaries have instituted, maintain and enforce policies and procedures reasonably
      designed to ensure compliance with Sanctions.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xxxix)</font>&#160;&#160;&#160;&#160;&#160;&#160; There is and has been no failure on the part of the Company, any of its subsidiaries or any of the Company&#8217;s or such
      subsidiaries&#8217; respective directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (the &#8220;<u>Sarbanes-Oxley Act</u>&#8221;), including
      Section 402 relating to loans and Sections 302 and 906 relating to certifications.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xl)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Neither the Company nor any of its subsidiaries, nor, to the knowledge of the Company, any director, officer, employee, agent or
      affiliate of the Company or any of its subsidiaries, acting on behalf of the Company or any of its subsidiaries, has taken any action, directly or indirectly, that violated or would result in a violation by such persons of any provision of the
      Foreign Corrupt Practices Act of 1977, as amended (the &#8220;<u>FCPA</u>&#8221;), the Bribery Act 2010 of the United Kingdom (the &#8220;<u>U.K. Bribery Act</u>&#8221;) or other applicable anti-bribery or anti-corruption laws, including (i) using any corporate funds for
      any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) making or taking an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment to any foreign or
      domestic government official or employee from corporate funds (including to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any political party or official thereof or any candidate for political office); or (iii) making, offering,
      agreeing, requesting or taking an act in furtherance of any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment or benefit. The Company, its subsidiaries and, to the knowledge of the Company, its affiliates have
      instituted, maintain and enforce policies and procedures designed to ensure compliance with the FCPA and the U.K. Bribery Act and other applicable anti-bribery and anti-corruption laws.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xli)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subsequent to the date of the most recent financial statements included or incorporated by reference in the Registration
      Statement, the General Disclosure Package and the Prospectus, (i) the Company and its subsidiaries have not (A) incurred any debt for borrowed money that is material to the Company and its subsidiaries, taken as a whole or (B) incurred any other
      liabilities or obligations, direct or contingent, nor entered into any transactions, in each case that are material, in the aggregate, to the Company and its subsidiaries, taken as a whole and not in the ordinary course of business; (ii) except for
      purchases made pursuant to publicly announced share repurchase programs (including the Share Repurchase), the Company and its subsidiaries have not purchased any of their outstanding capital stock, nor declared, paid or otherwise made any dividend or
      distribution of any kind on their capital stock; and (iii) there has not been any change in the capital stock (other than exercise of stock options or vesting of restricted stock units issued under equity incentive plans, stock option plans or
      restricted stock programs reported on the Company&#8217;s Annual Report on Form 20-F for the year ended December 31, 2022 and other than cancellations of shares purchased pursuant to publicly announced share repurchase programs) of the Company or its
      subsidiaries, in each case except as described in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xlii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The authorized, issued and outstanding capital stock of the Company is as set forth in the Registration Statement, the General
      Disclosure Package and the Prospectus as of the dates set forth therein. All of the issued and outstanding shares of capital stock of the Company, including the Securities, are fully paid and non-assessable and are and have been duly and validly
      authorized and issued, in compliance with all applicable federal, state and foreign securities laws and not in violation of or subject to any preemptive or similar rights that entitle or will entitle any person to acquire from the Company or any
      Significant Subsidiary, upon the issuance or sale of any Ordinary Shares, any other equity security of the Company or any Significant Subsidiary or any security convertible into, or exercisable or exchangeable for, any Ordinary Shares or other such
      security, except as described in the Registration Statement, the General Disclosure Package and the Prospectus.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xliii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company&#8217;s Ordinary Shares, including the Securities, are listed on the NYSE.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xliv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive
      of any amendment or supplement thereto), under current laws and regulations of the Netherlands and any political subdivision thereof, all dividends and other distributions declared and payable on the Securities may be paid by the Company to the
      holder thereof in United States dollars or euros and freely transferred out of the Netherlands and all such payments made to holders thereof who (i) are non-residents of the Netherlands and (ii) do not have a taxable presence in the Netherlands to
      which the Securities are attributable will not be subject to income, withholding or other taxes under laws and regulations of the Netherlands or any political subdivision or taxing authority thereof or therein and will otherwise be free and clear of
      any other tax, duty, withholding or deduction under the laws of the Netherlands or any political subdivision or taxing authority thereof or therein and without the necessity of obtaining any governmental authorization in the Netherlands or any
      political subdivision or taxing authority thereof or therein.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xlv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No relationship, direct or indirect, exists between or among the Company or its Significant Subsidiaries, on the one hand, and
      the Selling Shareholder and the directors, officers, shareholders, customers or suppliers of the Company or its Significant Subsidiaries, on the other hand, which is required by the Act or the Exchange Act to be described in the Registration
      Statement, the General Disclosure Package or the Prospectus which is not so described. To the Company&#8217;s knowledge, there are no outstanding loans, advances or guarantees of indebtedness by the Company to or for the benefit of any of the officers or
      directors of the Company or any of their respective family members which are prohibited by, or are required to be disclosed by, the Act, in the Registration Statement, the General Disclosure Package or the Prospectus which are not so disclosed.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xlvi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to the qualifications and limitations set forth in the Registration Statement, the General Disclosure Package and the
      Prospectus, the Company does not believe that it will be classified as a passive foreign investment company (&#8220;<u>PFIC</u>&#8221;), as defined in Section 1297 of the Internal Revenue Code of 1986, as amended, for 2022, and the Company also does not expect,
      based on its current operations and current law, to be classified as a PFIC for 2023.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xlvii)</font>&#160;&#160;&#160;&#160;&#160;&#160; Since the date of the most recent financial statements included or incorporated by reference in the Registration Statement, the
      General Disclosure Package and the Prospectus, there has been no material adverse change or development that would reasonably be expected to, singly or in the aggregate, result in a material adverse change in the condition (financial or otherwise),
      earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated by the Registration Statement, the General
      Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">Any certificate signed by any officer of the Company and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Securities shall be
      deemed a representation and warranty by the Company to each Underwriter as to matters covered thereby.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Selling Shareholder represents and warrants to, and agrees with, each Underwriter that:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#160;&#160;&#160; To the extent that any statements made in the Registration Statement, the General Disclosure Package and the Prospectus (in
      each case, exclusive of any amendment or supplement thereto) are made in reliance upon and in conformity with the Selling Shareholder Information (as defined below), (i) such statements made in the Registration Statement and any amendment thereto, as
      of each Effective Time, did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) such statements made in the
      General Disclosure Package did not and will not, as of the Applicable Time and at the Closing Date or Additional Closing Date, as the case may be, contain any untrue statement of a material fact or omit to state any material fact necessary to make
      the statements therein, in the light of the circumstances under which they were made, not misleading; and (iii) such statements made in the Prospectus, as then amended or supplemented, as of the Applicable Time, at the time filed with the Commission
      and as of the Closing Date or Additional Closing Date, as the case may be, did not and will not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the
      circumstances under which they were made, not misleading. Each of the Company, the Underwriters and the Selling Shareholder acknowledges and agrees that for all purposes of this Agreement, the only information furnished to the Company by or on behalf
      of the Selling Shareholder expressly for use in the Registration Statement, the General Disclosure Package and the Prospectus (the &#8220;<u>Selling Shareholder Information</u>&#8221;) is (i) the legal names of the Selling Shareholder as contained in the table
      under the heading &#8220;Selling Shareholder&#8221; in the Prospectus; (ii) information regarding the number of Ordinary Shares beneficially owned by the Selling Shareholder as contained in the table next to the name of the Selling Shareholder under the heading
      &#8220;Selling Shareholder&#8221; in the Prospectus; (iii) the number of Ordinary Shares proposed to be sold by the Selling Shareholder as contained in the table next to the name of the Selling Shareholder under the heading &#8220;Selling Shareholder&#8221; in the
      Prospectus; (iv) information regarding the number of Ordinary Shares beneficially owned by the Selling Shareholder after the sale of the Securities as contained in the table next to the name of the Selling Shareholder under the heading &#8220;Selling
      Shareholder&#8221; in the Prospectus; and (v) any applicable related footnotes as set forth under the heading &#8220;Selling Shareholder&#8221; in the Prospectus.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Selling Shareholder (including its agents and representatives, other than the Underwriters, each in their capacity as such
      and, for the avoidance of doubt, excluding the Company and its agents and representatives) has not, directly or indirectly, prepared, used, distributed, authorized, approved or referred to, and will not prepare or distribute, authorize, approve or
      refer to, any offering material in connection with the offering and sale of the Securities, including, without limitation, any Issuer Free Writing Prospectus or other Free Writing Prospectus or &#8220;written communication&#8221; (as defined in Rule 405 under
      the Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities, other than any Preliminary Prospectus, the Prospectus and each Permitted Free Writing Prospectus.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As of the Applicable Time, the Selling Shareholder is the beneficial owner of the Securities to be sold by it hereunder free and
      clear of all liens, encumbrances, equities and claims, and as of the Closing Date <font style="color: #000000;">or the Additional Closing Date, as the case may be,</font> and upon the consummation of the transactions contemplated by this Agreement,
      such Securities will be free and clear of all liens, encumbrances, equities and claims. Upon payment of the Securities to be sold by the Selling Shareholder hereunder, delivery of such Securities and the crediting of such shares on the books of The
      Depository Trust Company (&#8220;<u>DTC</u>&#8221;) to securities accounts of the several Underwriters (assuming that neither DTC nor any such Underwriter has notice (as defined in Section 8-105 of the New York Uniform Commercial Code (&#8220;<u>UCC</u>&#8221;)) of any
      adverse claim (within the meaning of Section 8-102(a)(1) of the UCC) to such Securities), then, assuming appropriate entries to the accounts of the several Underwriters on the records of DTC have been made pursuant to the UCC, the Underwriters will
      have acquired a security entitlement (within the meaning of Section 8-102(a)(17) of the UCC) to such Securities and no action based on an adverse claim (within the meaning of Section 8-102(a)(1) of the UCC) may be asserted against such Underwriters
      with respect to such security entitlement.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement has been duly authorized, executed and delivered by or on behalf of the Selling Shareholder. The Selling
      Shareholder has the full right, power and authority to perform its obligations hereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for the
      performance by the Selling Shareholder of its obligations under this Agreement, except such as may have been acquired or obtained, as may be required under the securities or blue sky laws of the various U.S. states in connection with the offer and
      sale of the Securities and any notice that may be required pursuant to Regulation 20 of the European Union (Markets in Financial Instruments) Regulations 2017 of Ireland.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;None of the execution, delivery or performance by the Selling Shareholder of its obligations under this Agreement, or the
      consummation of any other of the transactions herein contemplated, or the fulfillment of the terms hereof will contravene (i) the charter and by-laws of the Selling Shareholder, (ii) any agreement or other instrument binding upon the Selling
      Shareholder or any of its subsidiaries or (iii) any provision of applicable law or any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Selling Shareholder or any of its subsidiaries, except for, in the
      case of clauses (ii) and (iii) above, such contravention that would not, singly or in the aggregate, materially adversely affect the Selling Shareholder&#8217;s ability to perform its obligations under this Agreement or the Underwriter&#8217;s ability to
      consummate the transactions contemplated hereby.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The operations of the Selling Shareholder and its affiliates are and have been conducted at all times in material compliance
      with all applicable financial recordkeeping and reporting requirements, including (to the extent applicable) those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, Title III of the Uniting and Strengthening America by
      Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act) to the extent applicable to the Selling Shareholder and its affiliates, and applicable anti-money laundering statutes of jurisdictions where the
      Company or any of its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency, and no action, suit or proceeding by
      or before any court or governmental agency, authority or body or any arbitrator involving the Selling Shareholder or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the best knowledge of the Selling
      Shareholder, threatened.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Neither the Selling Shareholder nor any of its affiliates, nor, to the knowledge of the Selling Shareholder, any of their
      respective directors, officers, employees, agents or affiliates or anyone acting on their behalf, is currently the subject or the target of any Sanctions, administered or enforced by the U.S. government (including, without limitation, the OFAC or the
      U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European Union or HM Treasury or other relevant Sanctions, nor is the
      Selling Shareholder or any of its subsidiaries, except as permitted by applicable law, located, organized or resident in a Sanctioned Country and, except as permitted by applicable law, the Selling Shareholder and its subsidiaries will not, directly
      or indirectly use the proceeds of the offering (i) to fund or facilitate any activities of or business with any subsidiary, joint venture partner, or other person or entity that, at the time of such funding or facilitation, is the subject or target
      of any Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in the violation of Sanctions by any person (including any person participating in the transactions
      contemplated hereby, whether as underwriter, initial purchaser, advisor, investor or otherwise). The Selling Shareholder and its subsidiaries have instituted, maintain and enforce, policies and procedures reasonably designed to ensure compliance with
      Sanctions.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Selling Shareholder, nor any of its subsidiaries, nor, to the Selling Shareholder&#8217;s knowledge, any director, officer,
      employee, agent or affiliate of the Selling Shareholder or any of its subsidiaries, acting on behalf of the Selling Shareholder or any of its subsidiaries, has taken any action, directly or indirectly, that violated or would result in a violation by
      such persons of any provision of the FCPA, the U.K. Bribery Act or other applicable anti-bribery or anti-corruption laws, including (i) using any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to
      political activity; (ii) making or taking an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds (including to any
      &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any political party or official thereof or any candidate for political office); or (iii) making, offering, agreeing, requesting or taking an act in furtherance of any unlawful bribe, rebate,
      payoff, influence payment, kickback or other unlawful payment or benefit. The Selling Shareholder, its subsidiaries and, to the knowledge of the Selling Shareholder, its affiliates have instituted, maintain and enforce, policies and procedures
      designed to ensure compliance with the FCPA and the U.K. Bribery Act and other applicable anti-bribery and anti-corruption laws.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Selling Shareholder has not taken, nor will it take, directly or indirectly, any action designed, or that has constituted, or
      that might reasonably be expected to cause or result, under the Exchange Act or otherwise, the stabilization or manipulation of the price of the Ordinary Shares to facilitate the sale or resale of the Securities; provided, however, that such Selling
      Shareholder makes no representation or warranty in this clause (x) with respect to the Company.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Selling Shareholder will deliver to the Underwriters prior to or at the Closing Date a properly completed and executed United
      States Internal Revenue Service Form W-9 or W-8 (or other applicable form).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Purchase, Sale and Delivery of Securities</u>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the basis of the representations, warranties and agreements set forth herein and subject to the terms and conditions set forth
      herein, the Selling Shareholder agrees to sell to the several Underwriters, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the terms and conditions set forth herein, agrees,
      severally and not jointly, to purchase from the Selling Shareholder, at a price per share of $<font style="color: #000000;">63.62</font> per share (the &#8220;<u>Purchase Price</u>&#8221;), the respective number of Underwritten Shares set forth opposite such
      Underwriter&#8217;s name in Schedule I hereto. Subject to the sale of the Securities by the Selling Shareholder to the Underwriters in compliance with the terms of this Agreement, the Underwriters hereby agree to sell to the Company, and the Company hereby
      agrees to purchase from the Underwriters, the number of Repurchase Shares specified herein at the Purchase Price, as described in the General Disclosure Package and the Prospectus.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">In addition, on the basis of the representations, warranties and agreements </font>set forth herein<font style="color: #000000;"> and subject to the
        terms and conditions </font>set forth herein<font style="color: #000000;">, the Selling Shareholder agrees to sell to the several Underwriters, and each Underwriter, on the basis of the representations, warranties and agreements </font>set forth
      herein<font style="color: #000000;"> and subject to the terms and conditions </font>set forth herein, shall have the option to purchase, severally and not jointly, from the Selling Shareholder <font style="color: #000000;">the Option Shares at the
        Purchase Price.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 3.6pt; margin-left: 36pt; color: #000000;">If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares
      which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite such Underwriter&#8217;s name in Schedule I hereto (or such number increased as set forth in Section 9 hereof) bears
      to the aggregate number of Underwritten Shares being purchased from the Selling Shareholder by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Securities as the Representatives in their sole discretion
      shall make.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 3.6pt; margin-left: 36pt; color: #000000;">The Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the
      thirtieth day following the date of the Prospectus, by written notice from the Representatives to the Company and the Selling Shareholder. Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and
      the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as
      hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section 9 hereof). Any such notice shall be given at least two business days prior to the date and time of delivery
      specified therein.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Delivery of and payment for the Underwritten Shares shall be made at the office of Simpson Thacher &amp; Bartlett LLP, 425
      Lexington Avenue, New York, NY 10017, at 10:00 a.m., New York City time, on November 16, 2023, or at such other time or place on the same or such other date, not later than the second Business Day thereafter, as the Representatives, the Company and
      the Selling Shareholder may agree upon in writing or, in the case of Option Shares, on the date and at the time and place specified by the Representatives in the written notice of the Underwriters&#8217; election to purchase such Option Shares.&#160; The time
      and date of such payment for the Underwritten Shares is referred to herein as the &#8220;<u>Closing Date</u>&#8221;, and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as an &#8220;<u>Additional Closing
        Date</u>&#8221;. Delivery of the Securities shall be made to the Underwriters for their respective accounts against payment by the Underwriters of the aggregate purchase price of the Securities being sold by the Selling Shareholder to or upon the order
      of the Selling Shareholder by wire transfer payable in Federal (same-day) funds to the account specified by the Selling Shareholder. Delivery of the Securities shall be made through the facilities of The Depository Trust Company unless the
      Representatives shall otherwise instruct. In addition, subject to the sale of the Securities by the Selling Shareholder to the Underwriters in compliance with the terms of this Agreement, payment of the purchase price for the Repurchase Shares shall
      be made by the Company to the Underwriters in same day funds by wire transfer to an account specified by the Representatives, against delivery of such Repurchase Shares for the account of the Company on the Closing Date. &#8220;<u>Business Day</u>&#8221; shall
      mean any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorized or obligated by law to close in New York City.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">The Underwriters will pay all applicable U.S. state transfer taxes, if any, involved in the transfer to the Underwriters of the Securities to be purchased by them from the Selling
      Shareholder and the Selling Shareholder agrees to reimburse the Underwriters for associated carrying costs if such tax payment is not rebated on the day of payment. The Underwriters will pay any additional share transfer taxes involved in further
      transfers.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Offering by Underwriters</u>.&#160; It is understood that the Underwriters propose to, and will, offer the Securities for sale to the public as set
      forth in the Prospectus.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Agreements of the Company and the Selling Shareholder</u>.&#160; (a) <font style="color: #000000;">The Company agrees with each Underwriter
        that:</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company (i) will prepare and timely file (and advise the Representatives and the Selling Shareholder promptly of such filing)
      with the Commission under Rule 424(b) under the Act (without reliance on Rule 424(b)(8)) a Prospectus in a form approved by the Representatives containing information previously omitted at the time of effectiveness of the Registration Statement in
      reliance on Rules 430A, 430B or 430C under the Act, (ii) will not file any amendment to the Registration Statement or supplement (including the Prospectus) to the Base Prospectus unless the Company has furnished the Representatives with a copy for
      their review prior to filing and will not file any such proposed amendment or supplement to which the Representatives reasonably object, and (iii) file and/or furnish, as applicable, on a timely basis, all reports required to be filed or furnished,
      as the case may be, by the Company with the Commission for so long as the delivery of a prospectus is required in connection with the offering or sale of such Securities.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company (i) will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or
      that would otherwise constitute a Free Writing Prospectus unless the Representatives approve its use in writing prior to first use; provided that the prior written consent of the Representatives shall be deemed to have been given in respect of the
      Free Writing Prospectus(es) included in Schedule II and any electronic road show, (ii) has treated and will treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (iii) will comply with the requirements of Rules 163,
      164 and 433 under the Act applicable to any Permitted Free Writing Prospectus, including the requirements relating to timely filing with the Commission, legending and record keeping.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will advise the Representatives promptly (i) when the Prospectus, and any supplement thereto, shall have been filed
      (if required) with the Commission pursuant to Rule 424(b), (ii) when, prior to termination of the offering of the Securities, any amendment to the Registration Statement shall have been filed or become effective, (iii) of any request by the
      Commission or its staff for any amendment of the Registration Statement, or for any supplement to the Prospectus or for any additional information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the
      Registration Statement or of any notice objecting to its use or the institution or threatening of any proceeding for that purpose and (v) of the receipt by the Company of any notification with respect to the suspension of the qualification of the
      Securities for sale in any jurisdiction or the institution or threatening of any proceeding for such purpose. The Company will use commercially reasonable efforts to prevent the issuance of any such stop order or the occurrence of any such suspension
      or objection to the use of the Registration Statement and, upon such issuance, occurrence or notice of objection, to obtain as soon as possible the withdrawal of such stop order or relief from such occurrence or objection, including, if necessary, by
      filing an amendment to the Registration Statement or a new registration statement and using commercially reasonable efforts to have such amendment or new registration statement declared effective as soon as practicable.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Company receives from the Commission a notice pursuant to Rule 401(g)(2) under the Act or otherwise ceases to be eligible
      to use the automatic shelf registration statement form, the Company will (i) promptly notify the Representatives, (ii) promptly file a new registration statement or post-effective amendment on the proper form relating to the Securities, in a form
      satisfactory to the Representatives, (iii) use commercially reasonable efforts to cause such registration statement or post-effective amendment to be declared effective as soon as practicable (if such filing is not otherwise effective immediately
      pursuant to Rule 462 under the Act), and (iv) promptly notify the Representatives of such effectiveness. References herein to the Registration Statement relating to the Securities shall include such new registration statement or post-effective
      amendment, as the case may be.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company agrees to pay the required filing fees to the Commission relating to the Securities in accordance with Rules 456 and
      457 under the Act and in any event, prior to the Closing Date.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will cooperate with the Representatives in endeavoring to qualify the Securities for sale under the securities laws
      of such jurisdictions as the Representatives may reasonably request in writing and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose; provided the Company shall not be
      required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction where it is not now so qualified or required to file such a consent. The Company will, from time to time, prepare and file such
      statements, reports, and other documents, as are or may be required to continue such qualifications in effect for such period as delivery of a prospectus by the Underwriters may be required by the Act (including circumstances in which such
      requirement may be satisfied pursuant to Rule 172) (the &#8220;<u>Effectiveness Period</u>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As soon as practicable, the Company will make generally available to its security holders and to the Representatives an earnings
      statement or statements of the Company and its subsidiaries which will satisfy the provisions of Section 11(a) of the Act and Rule 158.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will deliver to each Representative and counsel for the Underwriters, without charge, as many copies of any
      Preliminary Prospectus or any Issuer Free Writing Prospectus, the Prospectus, and the Registration Statement (including such number of copies of the exhibits filed therewith that may reasonably be requested), including documents incorporated by
      reference therein and all amendments thereto as may reasonably be requested by the Representatives. The Company will pay the expenses of printing or other production of all documents related to the offering for the duration of the Effectiveness
      Period.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, during the Effectiveness Period, any event shall occur as a result of which, in the judgment of the Company, it becomes
      necessary to amend or supplement the Registration Statement or the Prospectus in order to make the statements therein (in the light of the circumstances existing at the time the Prospectus is delivered to a purchaser, in the case of the Prospectus),
      not misleading, or, if it is necessary at any time to amend or supplement the Registration Statement, file a new Registration Statement or supplement the Prospectus to comply with the Act or the Exchange Act, the Company will promptly notify the
      Representatives and either (i) prepare as soon as reasonably practicable and file with the Commission, subject to Section 5(a)(i) of this Agreement, an appropriate amendment to the Registration Statement and/or supplement to the Prospectus or (ii)
      prepare as soon as reasonably practicable and file with the Commission, subject to Section 5(a)(i) of this Agreement, an appropriate filing under the Exchange Act that shall be incorporated by reference in the Prospectus and the Registration
      Statement, so that each of the Prospectus and the Registration Statement as so amended or supplemented will not, in the light of the circumstances when it is so delivered, be misleading, or so that the Prospectus and the Registration Statement will
      comply with the law, (iii) use commercially reasonable efforts to have any amendment to the Registration Statement or new registration statement declared effective as soon as practicable in order to avoid any disruption in use of the Prospectus and
      (iv) supply any supplemented Prospectus to the Underwriters in such quantities as the Representatives may reasonably request.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the General Disclosure Package is being used to solicit offers to buy the Securities at a time when the Prospectus is not yet
      available to prospective purchasers and any event shall occur as a result of which it becomes necessary to amend or supplement the General Disclosure Package in order to make the statements therein, in the light of the circumstances, not misleading,
      or to make the statements therein not conflict with the information contained in the Registration Statement then on file, or if it is necessary at any time to amend or supplement the General Disclosure Package to comply with any law, the Company will
      promptly notify the Representatives and either (i) prepare as soon as reasonably practicable, and subject to Section 5(a)(i) of this Agreement, file with the Commission (if required) and furnish to the Representatives an appropriate amendment or
      supplement to the General Disclosure Package or (ii) prepare as soon as reasonably practicable and, subject to Section 5(a)(i) of this Agreement, file with the Commission an appropriate filing under the Exchange Act that shall be incorporated by
      reference in the General Disclosure Package so that the General Disclosure Package as so amended or supplemented will not, in the light of the circumstances, be misleading or conflict with the Registration Statement then on file, or so that the
      General Disclosure Package will comply with law.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will not take, directly or indirectly, any action designed to cause or result in or that would constitute or that
      might reasonably be expected to constitute, under the Exchange Act or otherwise, stabilization or manipulation of the price of the Ordinary Shares to facilitate the sale or resale of the Securities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For a period of 30 days after the date of the Prospectus, the Company will not (i) offer, pledge, sell, contract to sell, sell
      any option or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or file with the Commission a registration statement under the Act relating to, any Ordinary Shares or any securities convertible into or exercisable or
      exchangeable for Ordinary Shares, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of
      ownership of the Ordinary Shares or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Ordinary Shares or such other securities, in cash or otherwise, without the prior
      written consent of Goldman Sachs &amp; Co. LLC and Citigroup Global Markets Inc., other than (x) any Ordinary Shares issued upon the exercise of options or the vesting of equity awards granted under terms of any employee plan, benefit or compensation
      arrangement or employment agreement described in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto) and (y) the Share Repurchase.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xiii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company will use commercially reasonable efforts to maintain the listing of the Ordinary Shares on the NYSE.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xiv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company agrees with the Selling Shareholder and the Underwriters that the Company will pay all expenses incidental to the
      performance of or compliance with this Agreement, including, without limiting the generality of the foregoing, the following: the fees and disbursements of counsel for the Company; the cost of printing and delivering to, or as requested by, the
      Underwriters copies of the Registration Statement, any Preliminary Prospectuses, any Issuer Free Writing Prospectuses, and the Prospectus (including all exhibits, amendments and supplements thereto); the filing fees and expenses (including legal fees
      and disbursements) incident to securing any required review by FINRA of the terms of the sale of the Securities; the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of
      the Ordinary Shares under the state or foreign securities or blue sky laws of such jurisdictions as the Representatives may designate (including up to $5,000 of related fees and expenses of counsel for the Underwriters); the reasonable fees and
      expenses of one counsel to the Selling Shareholder; the cost of preparing stock certificates, including any cost related to printing, authentication, issuance and delivery thereof; the cost and charges of any transfer agent and any registrar; all
      expenses and application fees related to the listing of the Securities on the NYSE; and its internal expenses (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160; The Selling Shareholder agrees with the Company and the Underwriters that, except as otherwise provided in this Agreement,
      the Selling Shareholder will pay all expenses incidental to the performance of or compliance with the obligations of the Selling Shareholder under this Agreement, including, without limited the generality of the foregoing, the following:&#160; any stamp
      or other issuance, value added or transfer taxes or duties or other similar fees or charges imposed in connection with the execution and delivery of this Agreement and the sale or delivery of the Securities to the Underwriters; the expenses of any
      underwriting commissions or discounts relating to this Agreement; and its internal expenses (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#160;(ii) Prior to the Applicable Time, the Selling Shareholder shall have furnished to the Representatives a letter substantially in the form of Exhibit A hereto addressed to the
      Representatives.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All payments to be made by the Company and the Selling Shareholder to the Underwriters pursuant to this Agreement shall be made
      without any withholding or deduction for or on account of any present or future taxes, duties, or governmental charges unless the Company or the Selling Shareholder, as the case may be, is compelled by law to withhold or deduct such taxes, duties or
      charges. In that event, the Company or the Selling Shareholder, as the case may be, shall pay such additional amounts as may be necessary in order that the net amounts received after such withholding or deduction shall equal the amounts that would
      have been received if no withholding or deduction had been made; provided that no additional amounts shall be payable to an Underwriter with respect to taxes that arise by reason of any connection between the Underwriter and the applicable taxing
      jurisdiction other than a connection arising solely as a result of the transactions contemplated by this Agreement. All sums payable to an Underwriter shall be considered exclusive of any value added or similar taxes.&#160; Where the Company or the
      Selling Shareholder is obliged to pay value added or similar tax on any amount payable hereunder to an Underwriter, the Company or the Selling Shareholder, as the case may be, shall in addition to the sum payable hereunder pay an amount equal to any
      applicable value added or similar tax.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Conditions of the Obligations of the Underwriters</u>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The obligations of each Underwriter to purchase and pay for the Ordinary Shares on the Closing Date or the Option Shares on an
      Additional Closing Date shall be subject to the accuracy of the representations and warranties on the part of the Company and the Selling Shareholder herein as of such Applicable Time and on the Closing Date or the Additional Closing Date, as the
      case may be, to the accuracy of the statements of Company&#8217;s officers and the Selling Shareholder&#8217; officers made pursuant to the provisions hereof, to the performance by the Company and the Selling Shareholder of their obligations hereunder and to the
      following additional conditions precedent:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At the Applicable Time and at the Closing Date or the Additional Closing Date, as the case may be, the Company shall have
      requested and caused KPMG Ireland to furnish to the Representatives letters, dated respectively as of the Applicable Time and as of the Closing Date or the Additional Closing Date, as the case may be, in form and substance satisfactory to the
      Representatives and confirming that they are independent accountants within the meaning of the Exchange Act and the applicable published rules and regulations thereunder and containing statements and information of the type customarily included in
      accountants&#8217; &#8220;comfort letters&#8221; to purchasers with respect to the financial statements and certain financial information contained in the Registration Statement, the General Disclosure Package and the Prospectus; provided that such letter shall use a
      &#8220;cut-off&#8221; date not earlier than three business days prior to the date of the letter.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At the Applicable Time and at the Closing Date or the Additional Closing Date, as the case may be, the Company shall have
      requested and caused PricewaterhouseCoopers to furnish to the Representatives letters, dated respectively as of the Applicable Time and as of the Closing Date or the Additional Closing Date, as the case may be, in form and substance satisfactory to
      the Representatives and containing statements and information of the type customarily included in accountants&#8217; &#8220;comfort letters&#8221; to purchasers with respect to the financial statements and certain financial information contained in the Registration
      Statement, the General Disclosure Package and the Prospectus.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A) The Registration Statement and all post-effective amendments thereto shall have become effective and the Prospectus and each
      Issuer Free Writing Prospectus required to be filed shall have been filed as required by Rules 424(b) (without reliance on Rule 424(b)(8)), 430A, 430B, 430C or 433 under the Act, as applicable, within the time periods prescribed by, and in compliance
      with, the Act, and any request of the Commission for additional information (to be included in the Registration Statement, the Prospectus or otherwise) shall have been disclosed to the Representatives and complied with to their reasonable
      satisfaction.&#160; (B) No stop order suspending the effectiveness of, or preventing or suspending the use of, the Registration Statement, as amended from time to time, or the Prospectus or any Issuer Free Writing Prospectus or any amendment or supplement
      to any of the foregoing shall have been issued and no proceedings for that purpose or pursuant to Section 8A under the Act shall have been taken or, to the knowledge of the Company, shall be contemplated or threatened by the Commission and no
      injunction, restraining order or order of any nature by any Federal or state court of competent jurisdiction shall have been issued as of the Closing Date or the Additional Closing Date, as the case may be, which would prevent the issuance of the
      Securities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent to the execution and delivery of this Agreement, there shall not have occurred any (i) change, or any development
      involving a prospective change, in or affecting the condition (financial or otherwise), earnings, business or properties of the Company and its subsidiaries taken as a whole, whether or not arising from transactions in the ordinary course of
      business, except as set forth in or contemplated in the Registration Statement, the General Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), the effect of which is, in the sole judgment of the
      Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the public offering, sale or delivery of the Securities, (ii) decrease in the rating of any of any of the Company&#8217;s securities by any &#8220;nationally
      recognized statistical rating organization&#8221; (as defined in Section 3(a)(62) of the Exchange Act) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the
      direction of the possible change, (iii) change in U.S. or international financial, political or economic conditions or currency exchange rates or exchange controls as would, in the sole judgment of the Representatives, be likely to prejudice
      materially the success of the proposed issue, sale or distribution of the Securities, whether in the primary market or in respect of dealings in the secondary market, (iv) suspension or material limitation of trading in securities generally on the
      NYSE or any establishment of minimum prices on such exchange, (v) suspension of trading of any securities issued or guaranteed by the Company on any exchange or in any over-the-counter market, (vi) declaration of a general banking moratorium on
      commercial banking activities by the Netherlands, Ireland or U.S. federal or New York State authorities, or (vii) outbreak or escalation of hostilities, declaration by the Netherlands, Ireland or the United States of a national emergency or war or
      other calamity or crisis the effect of which on financial markets is such as to make it, in the sole judgment of the Representatives, impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by this
      Agreement.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(v)</font>&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; The Representatives shall have received an opinion, dated as of the Closing Date or the Additional Closing Date, as the case may
      be, and addressed to the Representatives, of NautaDutilh N.V., Dutch counsel for the Company, substantially in the form heretofore agreed upon among the Company and the Representatives.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Representatives shall have received an opinion and letter, dated as of the Closing Date or the Additional Closing Date, as
      the case may be, and addressed to the Representatives, of Cravath, Swaine &amp; Moore LLP, U.S. counsel for the Company, substantially in the form heretofore agreed upon among the Company and the Underwriters.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Representatives shall have received an opinion, dated as of the Closing Date or the Additional Closing Date, as the case may
      be, and addressed to the Representatives, of Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP, U.S. counsel for the Selling Shareholder, substantially in the form heretofore agreed upon among the Selling Shareholder and the Representatives.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Representatives shall have received from Simpson Thacher &amp; Bartlett LLP, U.S. counsel for the Underwriters, such
      opinion or letter, dated as of the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Representatives, with respect to the sale of the Securities, the Registration Statement, the General Disclosure Package, the
      Prospectus and other related matters as the Representatives may require, and the Company and the Selling Shareholder shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such
      matters.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall have furnished to the Representatives a certificate of the Company, signed by (x) the Chairman of the Board or
      the Chief Executive Officer of the Company and (y) the principal financial or accounting officer of the Company, dated the Closing Date or the Additional Closing Date, as the case may be, to the effect that the signers of such certificate have
      carefully examined the Registration Statement, the General Disclosure Package, the Prospectus and this Agreement and that:</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;"><font style="color: #000000;">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the representations and warranties of the Company in this Agreement are true and correct on and as of the Closing Date or the
      Additional Closing Date, as the case may be, with the same effect as if made on the Closing Date or the Additional Closing Date, as the case may be, and the Company has complied with all the agreements and satisfied all the conditions on its part to
      be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;"><font style="color: #000000;">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;since the date of the most recent financial statements included or incorporated by reference in the Registration Statement, the
      General Disclosure Package and the Prospectus, there has been no material adverse change or development that could reasonably be expected to, singly or in the aggregate, result in a material adverse change in the condition (financial or otherwise),
      earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Registration Statement, the General
      Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall have complied with any request by the Representatives with respect to the furnishing of copies of the Prospectus
      in compliance with the provision of Section 5(a)(viii) hereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Representatives shall have received a certificate, dated as of the Closing Date or the Additional Closing Date, as the case
      may be, of the Chief Executive Officer or any Executive Vice President of the Selling Shareholder in which such individual shall state, in the signer&#8217;s capacity as an officer and on behalf of such Selling Shareholder that, to the best of the signer&#8217;s
      knowledge: (i) the representations and warranties of the Selling Shareholder in this Agreement are true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be, with the same effect as if made on the Closing Date
      or the Additional Closing Date, as the case may be; and (ii) such Selling Shareholder has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional
      Closing Date, as the case may be.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Representatives shall have received as of the Closing Date or the Additional Closing Date, as the case may be, a certificate
      of the Company certifying the Company&#8217;s articles of association and corporate approvals and satisfactory evidence of the good standing of the Company&#8217;s subsidiaries in their respective jurisdictions of organization and their good standing as foreign
      entities in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xiii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Securities to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall be listed on the
      NYSE.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xiv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company and the Selling Shareholder
      shall have furnished to the Representatives such further information, certificates and documents as the Representatives may reasonably request.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(xv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Selling Shareholder and the Company each, severally and not jointly, agree to furnish the Underwriters with such conformed
      copies of such opinions, certificates, letters and documents as the Representatives reasonably request. The Representatives may in its sole discretion waive compliance with any conditions to the obligations of the Underwriters hereunder, whether in
      respect of the Closing Date or the Additional Closing Date, as the case may be, or otherwise.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">If any of the conditions specified in this Section 6 shall not have been fulfilled when and as provided in this Agreement, or if any of the opinions and certificates mentioned above or elsewhere in
      this Agreement shall not be reasonably satisfactory in form and substance to the Representatives and counsel for the Underwriters, this Agreement and all obligations of the Underwriters hereunder may be canceled at, or at any time prior to, the
      Closing Date or the Additional Closing Date, as the case may be, by the Underwriters. Notice of such cancellation shall be given to the Company and the Selling Shareholder in writing (including via electronic mail) or by telephone or facsimile
      confirmed in writing.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification and Contribution</u>.&#160; (a) The Company will indemnify and hold harmless each Underwriter, its directors, officers, employees, and
      agents and the affiliates of such Underwriter and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, against any and all losses, claims, damages or liabilities, joint or
      several, to which any such person or entity may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged
      untrue statement of a material fact contained in the Registration Statement or any amendment thereto or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
      therein not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, in the Prospectus, any Issuer Free Writing Prospectus, any &#8220;issuer information&#8221; filed or required to be filed
      pursuant to Rule 433(d) under the Act, any other Free Writing Prospectus or &#8220;written communication&#8221; (as defined in Rule 405 under the Act), the General Disclosure Package (or, in each case, any amendment or supplement to any of the foregoing,
      including the General Disclosure Package as subsequently amended or supplemented), or caused by any omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they
      were made, not misleading, and will reimburse each indemnified party for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are
      incurred; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement in or omission or alleged
      omission made in reliance upon and in conformity with the Underwriter Information or the Selling Shareholder Information.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Selling Shareholder will indemnify and hold harmless each&#160; Underwriter, its directors, officers, employees, and agents and the
      affiliates of such Underwriter and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, against any and all losses, claims, damages or liabilities, joint or several, to
      which any such person or entity may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement
      of a material fact contained in the Registration Statement or any amendment thereto or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein not
      misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, in the Prospectus, any Issuer Free Writing Prospectus, any other Free Writing Prospectus or &#8220;written communication&#8221; (as
      defined in Rule 405 under the Act), the General Disclosure Package (or, in each case, any amendment or supplement to any of the foregoing, including the General Disclosure Package that has subsequently been amended or supplemented), or caused by any
      omission or alleged omission to state therein a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case, to the extent, but only to the extent, that such
      untrue statement or alleged untrue statement or omission or alleged omission relates to the Selling Shareholder Information; and will reimburse each indemnified party for any legal or other expenses reasonably incurred by them in connection with
      investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, that the Selling Shareholder&#8217;s obligation to indemnify and hold harmless hereunder will be limited to the net amount of proceeds
      received by the Selling Shareholder from the offering of the Securities pursuant to this Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, officers,
      employees, agents and affiliates and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, and the Selling Shareholder, its directors, officers, employees, agents and affiliates
      and each person, if any, who controls the Selling Shareholder within the meaning of Section 15 of the Act or Section 20 of the Exchange Act against any and all losses, claims, damages or liabilities to which any such person or entity may become
      subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the
      Registration Statement or any amendment thereto or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (ii) any untrue statement or
      alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Prospectus or the General Disclosure Package (or, in each case, any amendment or supplement to any of the foregoing, including the General Disclosure Package as
      subsequently amended or supplemented) or caused by any omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case to
      the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with the written information furnished to the Company by or on behalf of such
      Underwriter through the Representatives expressly for use in the Registration Statement, the General Disclosure Package and the Prospectus (the &#8220;<u>Underwriter Information</u>&#8221;) and will reimburse any legal or other expenses reasonably incurred by an
      indemnified party in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; it being understood and agreed upon that the Underwriter Information consists only of (i) the name of
      such Underwriter, (ii) the sentence related to concessions and reallowances and (iii) the information under the heading &#8220;Price Stabilization, Syndicate Covering Transactions and Penalty Bids&#8221; under the caption &#8220;Underwriting&#8221; in the Prospectus.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promptly after receipt by an indemnified party under this Section 7 of notice of the commencement of any action, such indemnified
      party will, if a claim in respect thereof is to be made against an indemnifying party under paragraph (a), (b) or (c) above, notify the indemnifying party of the commencement thereof; but the failure to notify the indemnifying party (i) shall not
      relieve it from any liability that it may have under paragraph (a), (b) or (c) above except and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and
      defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a), (b) or (c) above. The indemnifying party shall be entitled to
      appoint counsel (including local counsel) of the indemnifying party&#8217;s choice at the indemnifying party&#8217;s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not
      thereafter be responsible for the fees and expenses of any separate counsel, other than one local counsel in each jurisdiction in which proceedings have been brought, if not appointed by the indemnifying party or retained by the indemnified party or
      parties except as set forth below); provided, however, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party&#8217;s election to appoint counsel (including local counsel) to represent the
      indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including local counsel), and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel if (i) the use of
      counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict of interest; (ii) the actual or potential defendants in, or targets of, any such action include both the indemnified party and the
      indemnifying party and the indemnified party shall have reasonably concluded that there may be legal defenses available to it and/or other indemnified parties that are different from or additional to those available to the indemnifying party; (iii)
      the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of the institution of such action; or (iv) the indemnifying party shall
      authorize the indemnified party to employ separate counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any
      judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or
      action) unless such settlement, compromise or consent (x) includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and (y) does not include any statement as to or any
      admission of fault, culpability or a failure to act by or on behalf of any indemnified person.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless an indemnified party under
      subsection (a), (b) or (c) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) for which indemnification is provided by an indemnifying party therein, then each indemnifying party shall contribute to the
      amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a), (b) or (c) above (i) in such proportion as is appropriate to reflect the relative benefits received by the
      Company and the Selling Shareholder, on the one hand, and the Underwriters on the other, respectively, from the offering of the Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law or if unavailable for
      any reason, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and the Selling Shareholder, on the one hand, or the Underwriters, on the other,
      respectively, in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof) from the offering of the Securities as well as any other relevant equitable considerations. The
      relative benefits received by the Company and the Selling Shareholder, on the one hand, and the Underwriters, on the other, shall be deemed to be in the same respective proportions as the net proceeds (after deducting underwriting commissions and
      discounts, but before deducting expenses) received by the Selling Shareholder from the sale of the Securities and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth on the
      cover page of the Prospectus. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to
      information supplied by the Company and the Selling Shareholder, on the one hand, and the Underwriters on the other and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or
      omission. The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to in the first sentence of this subsection (e) shall be deemed to include any legal or other
      expenses reasonably incurred by such indemnified party in connection with investigating or defending any action or claim which is the subject of this subsection (e). The Company, the Selling Shareholder and the Underwriters agree that it would not be
      just and equitable if contribution were determined by <font style="font-style: italic;">pro rata</font> allocation or any other method of allocation which does not take account of the equitable considerations referred to above. Notwithstanding the
      provisions of this subsection (e), (1) no Underwriter shall be required to contribute any amount in excess of the amount by which the underwriting discounts and commissions received by such Underwriter with respect to the offering of the Securities
      exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission and (2) the Selling Shareholder shall not be required to contribute any
      amount in excess of the amount by which (A) the net proceeds received by the Selling Shareholder from the sale of Securities exceeds (B) the amount of any damages which the Selling Shareholder have otherwise been required to pay by reason of such
      untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such
      fraudulent misrepresentation. For purposes of this subsection (e), (i) each person who controls an Underwriters within the meaning of Section 15 of the Act or Section 20 of the Exchange Act and director, officer, employee, agent and affiliate of an
      Underwriter shall have the same rights to contribution as such Underwriter, (ii) each person who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act and each director, officer, employee, agent and
      affiliate of the Company shall have the same rights to contribution as the Company and (iii) each person who controls the Selling Shareholder within the meaning of Section 15 of the Act or Section 20 of the Exchange Act and each director, officer,
      employee, agent and affiliate of the Selling Shareholder shall have the same rights to contribution as the Selling Shareholder, subject in each case to the applicable terms and conditions of this subsection (e).</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The obligations of the Company and the Selling Shareholder under this Section shall be in addition to any liability which the
      Company and the Selling Shareholder may otherwise have.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Termination; Survival of Certain Representations and Obligations; Certain Expenses</u>.&#160; If any of the conditions set forth in Section 6 hereof are
      not satisfied on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date, or the parties hereto breach their obligations hereunder, this Agreement and the obligations hereunder may be terminated by the
      Representatives in their absolute discretion. The reimbursement, indemnification and contribution agreements contained in this Agreement and the representations, warranties and covenants in this Agreement shall remain in full force and effect
      regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Underwriter or any controlling person of the foregoing, or by or on behalf of the Company or its directors or officers or by or on behalf of the
      Selling Shareholder or their directors or officers and (iii) delivery of and payment for the Securities under this Agreement and the sale of the Securities. If this Agreement is terminated pursuant to this Section 8 or if for any reason the purchase
      of the Securities by the Underwriters is not consummated, each of the Selling Shareholder and the Company shall remain responsible for the expenses to be paid or reimbursed by it pursuant to Section 7 and the respective obligations of the Company,
      the Selling Shareholder and the Underwriters pursuant to Section 7 shall remain in effect, and if any Securities have been purchased hereunder the representations and warranties in Section 2 and all obligations under Section 5 shall also remain in
      effect. In addition, if the purchase of the Securities by the Underwriters is not consummated for any reason, other than the termination of this Agreement pursuant to Section 9 hereof, the Company and the Selling Shareholder will reimburse the
      Underwriters for all out-of-pocket expenses (including fees and disbursements of counsel) reasonably incurred by them in connection with the offering of the Securities. The provisions of Sections 7 and Section 8 hereof shall survive the termination
      or cancellation of this Agreement.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Defaulting Underwriter</u>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Securities
      that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Company and the Selling Shareholder on the terms contained
      in this Agreement.&#160; If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Securities, then the Company and the Selling Shareholder shall be entitled to a further period
      of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such Securities on such terms.&#160; If other persons become obligated or agree to purchase the Securities of a defaulting Underwriter, the
      non-defaulting Underwriters, the Company or the Selling Shareholder may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five business days in order to effect any changes that, in the opinion of counsel for the
      Company, counsel for the Selling Shareholder or counsel for the Underwriters may be necessary to the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or
      supplement to the Registration Statement and the Prospectus that effects any such changes.&#160; As used in this Agreement, the term &#8220;Underwriter&#8221; includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in
      Schedule I hereto that, pursuant to this Section 9, purchases Securities that a defaulting Underwriter agreed but failed to purchase.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting
      Underwriters, the Company and the Selling Shareholder as provided in paragraph (a) above, the aggregate number of Securities that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh
      of the aggregate number of Securities to be purchased on such date, then the Company and the Selling Shareholder shall have the right to require each non-defaulting Underwriter to purchase the number of Securities that such Underwriter agreed to
      purchase hereunder on such date plus such Underwriter&#8217;s pro rata share (based on the number of Securities that such Underwriter agreed to purchase on such date) of the Securities of such defaulting Underwriter or Underwriters for which such
      arrangements have not been made.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting
      Underwriters, the Company and the Selling Shareholder as provided in paragraph (a) above, the aggregate number of Securities that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be exceeds one-eleventh of the
      aggregate amount of Securities to be purchased on such date, or if the Company and the Selling Shareholder shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect to any Additional Closing Date, the
      obligation of the Underwriters to purchase Option Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of the non-defaulting Underwriters.&#160; Any termination of this Agreement pursuant to this Section
      9 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section 5(a) hereof, the Selling Shareholder will continue to be liable for the payment of
      expenses as set forth in Section 5(b) hereof and the provisions of Section 7 hereof shall not terminate and shall remain in effect.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for
      damages caused by its default.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; All communications hereunder will be in writing and effective only upon receipt, if sent to the Representatives, will be mailed,
      delivered or telefaxed and confirmed to the Underwriters: Goldman Sachs &amp; Co. LLC, 200 West Street, New York, New York 10282 Attention: Registration Department (facsimile: 1-212-902-9316) (email: registration-syndops@ny.email.gs.com); Citigroup
      Global Markets Inc., 388 Greenwich Street, New York, New York 10013 Attention: General Counsel (facsimile: 1-646-291-1469); <font style="color: #000000;">Deutsche Bank Securities Inc., 1 Columbus Circle, New York, New York 10019, Attention: Equity
        Capital Markets &#8211; Syndicate Desk, with a copy to Deutsche Bank Securities Inc., 1 Columbus Circle, 19th Floor, New York, New York 10019, Attention: General Counsel (email: dbcapmarkets.gcnotices@list.db.com); </font>or, if sent to the Company,
      will be mailed, delivered or telefaxed and confirmed to AerCap Holdings N.V., at AerCap House, 65 St. Stephen&#8217;s Green, Dublin D02 YX20, Ireland, Attention: Legal Department; or, if sent to the Selling Shareholder, will be mailed, delivered or
      telefaxed and confirmed to GE Capital US Holdings, Inc., c/o General Electric Company, 901 Main Avenue, Norwalk, Connecticut 06851, Attention: Fred Robustelli (email: Fred.Robustelli@ge.com).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors</u>.&#160; This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the
      officers and directors and controlling persons referred to in Section 7, and no other person will have any right or obligation hereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>.&#160; This Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together
      shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by telecopier, facsimile, electronic mail (including any electronic signature complying with the New York Electronic Signatures and
      Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law) or other transmission method shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Advisory or Fiduciary Responsibility</u>.&#160; The Company, the Selling Shareholder, and the Underwriters acknowledge and agree that (i) the
      purchase and sale of the Securities pursuant to this Agreement is an arm&#8217;s-length commercial transaction between the Company, and/or the Selling Shareholder, on the one hand, and the Underwriters, on the other, (ii) in connection therewith and with
      the process leading to such transaction the Underwriters are acting solely as principals and not the agents or fiduciaries of the Company or the Selling Shareholder, (iii) no Underwriter has assumed an advisory or fiduciary responsibility in favor of
      the Company or the Selling Shareholder with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company or the Selling Shareholder on other
      matters) or any other obligation to the Company or the Selling Shareholder except the obligations expressly set forth in this Agreement, (iv) each of the Company and the Selling Shareholder has consulted its own legal and financial advisors to the
      extent it deemed appropriate, and (v) although the Underwriters may provide certain Regulation Best Interest documentation in connection with the offering, the Underwriters are not making a recommendation to participate in the offering or sell any
      Securities at the price determined in the offering and nothing set forth in such disclosures or documentation is intended to suggest that any Underwriter is making such a recommendation. Each of the Company and the Selling Shareholder agrees that it
      will not claim that any Underwriter has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company or the Selling Shareholder, in connection with such transaction or the process leading thereto.
      Furthermore, the Company and the Selling Shareholder agree that they are solely responsible for making their own judgments in connection with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the
      Company or the Selling Shareholder on related or other matters). Moreover, the Selling Shareholder acknowledges and agrees that, although the Representatives may be required or choose to provide the Selling Shareholder with certain Regulation Best
      Interest and Form CRS disclosures in connection with the offering, the Representatives and the other Underwriters are not making a recommendation to the Selling Shareholder to participate in the offering, enter into a &#8220;lock-up&#8221; agreement, or sell any
      Securities at the price determined in the offering, and nothing set forth in such disclosures is intended to suggest that the Representatives or any Underwriters are making such a recommendation.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">35</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>APPLICABLE LAW</u>.&#160; THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING
      EFFECT TO ANY CONFLICTS OF LAW PRINCIPLES THAT WOULD APPLY THE LAW OF ANOTHER JURISDICTION.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Integration</u>.&#160; This Agreement supersedes all prior agreements and understanding (whether written or oral) among the Company, the Selling
      Shareholder and the Underwriters with respect to the subject matter hereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">16.</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Jurisdiction</u>.&#160; The Company and the Selling Shareholder hereby submit to the exclusive jurisdiction of the Federal and state courts in the
      Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby and irrevocably and unconditionally waive any objections to the laying of venue of any such
      suit or proceeding arising out of or relating to this Agreement or any transactions contemplated hereby in a Federal or state court in the Borough of Manhattan in The City of New York, and irrevocably and unconditionally waive and agree not to plead
      or claim in any such court that any such suit or proceeding in any such court has been brought in an inconvenient forum. The Company irrevocably appoints CT Corporation System, with offices at 28 Liberty Street, New York, NY, 10005, as its authorized
      agent in the Borough of Manhattan in The City of New York upon which process may be served in any such suit or proceeding. The Company agrees that service of process upon such agent, and written notice of said service to the Company by the person
      serving the same to the address provided in Section 10, shall be deemed in every respect effective service of process upon the Company in any such suit or proceeding. The Company further agrees to take any and all action as may be necessary to
      maintain such designation and appointment of such agent in full force and effect for a period of seven years from the date of this Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Jury Trial</u>.&#160; Each of the Company, the Selling Shareholder and the Underwriters irrevocably waives, to the fullest extent permitted
      by law, any and all rights to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">36</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Waiver of Immunity</u>.&#160; With respect to any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
      hereby, each party irrevocably waives, to the fullest extent permitted by applicable law, all immunity (whether on the basis of sovereignty or otherwise) from jurisdiction, service of process, attachment (both before and after judgment) and execution
      to which it might otherwise be entitled, and with respect to any such suit or proceeding, each party waives any such immunity in any court of competent jurisdiction, and will not raise or claim or cause to be pleaded any such immunity at or in
      respect of any such suit or proceeding, including, without limitation, any immunity pursuant to the U.S. Foreign Sovereign Immunities Act of 1976, as amended.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Currency</u>.&#160; The obligation of the Company or the Selling Shareholder in respect of any sum due to any of the Underwriters shall, notwithstanding
      any judgment in a currency other than United States dollars, not be discharged until the first Business Day, following receipt by such Underwriter of any sum adjudged to be so due in such other currency, on which (and only to the extent that) such
      Underwriter may in accordance with normal banking procedures purchase United States dollars with such other currency; if the United States dollars so purchased are less than the sum originally due to such Underwriter hereunder, the Company and the
      Selling Shareholder agree, as a separate obligation and notwithstanding any such judgment, to indemnify such Underwriter against such loss. If the United States dollars so purchased are greater than the sum originally due to such Underwriter
      hereunder, such Underwriter agrees to pay to the Company or the Selling Shareholder an amount equal to the excess of the dollars so purchased over the sum originally due to such Underwriter hereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: #000000;">20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Recognition of the U.S. Special Resolution Regimes</u>.&#160; In the event that any Underwriter is a Covered Entity and becomes subject to a proceeding
      under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special
      Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. In the event that any Underwriter is a Covered Entity or a BHC Act Affiliate of such
      Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could
      be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. For the purposes of this Section 20:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>BHC Act Affiliate</u>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12
      U.S.C. &#167;&#160;1841(k).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Covered Entity</u>&#8221; means any of the following:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;252.82(b);</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;47.3(b); or</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">37</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: #000000;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;382.2(b).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Default Right</u>&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167;&#160;252.81,
      47.2 or 382.1, as applicable.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: #000000;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>U.S. Special Resolution Regime</u>&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated
      thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-style: italic;">(Signatures pages follow)</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">38</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">If the foregoing is in accordance with your understanding of our agreement, kindly sign and return to the Company one of the counterparts hereof, whereupon it will become a binding agreement among
      the Company, the Selling Shareholder and the Underwriters in accordance with its terms.&#160; <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"> <br>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5d10ef85b2604942a1b9baed51fc20c2">

            <tr>
              <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
              <td colspan="4" style="vertical-align: top;" rowspan="1">Very truly yours,</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
              <td colspan="4" style="vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td colspan="4" style="vertical-align: top;">
                <div style="font-family: 'Times New Roman';">AERCAP HOLDINGS N.V. </div>
              </td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td colspan="4" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';"><br>
                </div>
              </td>
              <td style="width: 3.36%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';">By:</div>
              </td>
              <td colspan="2" style="vertical-align: top;">
                <div style="font-family: 'Times New Roman';">/s/ Peter Juhas </div>
              </td>
              <td style="width: 13.34%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td style="width: 3.36%; vertical-align: top;">&#160;</td>
              <td style="width: 4.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">Name:</div>
              </td>
              <td style="width: 34.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                <div style="font-family: 'Times New Roman';">Peter Juhas </div>
              </td>
              <td style="width: 13.34%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 44.37%; vertical-align: top;">&#160;</td>
              <td style="width: 3.36%; vertical-align: top;">&#160;</td>
              <td style="width: 4.45%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';">Title:</div>
              </td>
              <td style="width: 34.39%; vertical-align: top;">
                <div style="font-family: 'Times New Roman';">Chief Financial Officer </div>
              </td>
              <td style="width: 13.34%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <br>
      </div>
    </div>
    <div style="text-align: center; color: #000000; font-style: italic;">(Signatures continue on the next page)</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>The foregoing Agreement is hereby confirmed and accepted as of the date hereof.</div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr>
              <td valign="top" style="width: 44%;">&#160;</td>
              <td valign="top" style="font-weight: normal;" colspan="3">GE CAPITAL US HOLDINGS, INC.</td>
              <td valign="top" style="width: 13%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 44%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" colspan="2">&#160;</td>
              <td valign="top" style="width: 13%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" align="left" style="width: 44%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                </div>
              </td>
              <td valign="top" style="width: 3%; padding-bottom: 2px;">
                <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
              </td>
              <td valign="top" nowrap="nowrap" align="left" style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">/s/ Robert M. Giglietti <br>
              </td>
              <td valign="top" style="width: 13%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 44%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
              <td valign="bottom" nowrap="nowrap" align="left" style="width: 34%;">Robert M. Giglietti <br>
              </td>
              <td valign="top" style="width: 13%;">&#160;</td>
            </tr>
            <tr>
              <td valign="top" style="width: 44%;">&#160;</td>
              <td valign="top" style="width: 3%;">&#160;</td>
              <td valign="top" style="width: 4%;">Title:</td>
              <td valign="top" style="width: 34%;">
                <div>Chief Financial Officer and Senior</div>
                <div> Vice President <br>
                </div>
              </td>
              <td valign="top" style="width: 13%;">&#160;</td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">[Signature Page to Underwriting Agreement]</div>
    </div>
    <br>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>The foregoing Agreement is hereby confirmed and accepted as of the date hereof.</div>
    <div><br>
    </div>
    <div>
      <div>
        <div><br>
        </div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                  <td colspan="4" style="vertical-align: top;">
                    <div style="font-family: 'Times New Roman';">GOLDMAN SACHS &amp; CO. LLC</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                  <td colspan="4" style="vertical-align: top;" rowspan="1">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                  <td colspan="4" style="vertical-align: top; font-family: 'Times New Roman';" rowspan="1">
                    <div>For itself and on behalf of the<br>
                      several Underwriters listed<br>
                      in Schedule I hereto.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                  <td colspan="4" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 44.37%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman';"><br>
                    </div>
                  </td>
                  <td style="width: 3.36%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman';">By:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div style="font-family: 'Times New Roman';">/s/ Charlie Black <br>
                    </div>
                  </td>
                  <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                  <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                  <td style="width: 4.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman';">Name:</div>
                  </td>
                  <td style="width: 34.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman';"> </div>
                    Charlie Black<br>
                  </td>
                  <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                  <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                  <td style="width: 4.45%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman';">Title:</div>
                  </td>
                  <td style="width: 34.39%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman';"> </div>
                    Managing Director<br>
                  </td>
                  <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                </tr>

            </table>
            <div><br>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div><br>
    </div>
    <br>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">[Signature Page to Underwriting Agreement]</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>The foregoing Agreement is hereby confirmed and accepted as of the date hereof.</div>
    <div><br>
    </div>
    <div>
      <div>
        <div>
          <div><br>
          </div>
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td colspan="4" style="vertical-align: top; font-family: 'Times New Roman';">
                      <div>
                        <div>CITIGROUP GLOBAL MARKETS INC.</div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                    <td colspan="4" style="vertical-align: top;" rowspan="1">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                    <td colspan="4" style="vertical-align: top; font-family: 'Times New Roman';" rowspan="1">
                      <div>For itself and on behalf of the<br>
                        several Underwriters listed<br>
                        in Schedule I hereto.</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td colspan="4" style="vertical-align: top;">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">
                      <div style="font-family: 'Times New Roman';"><br>
                      </div>
                    </td>
                    <td style="width: 3.36%; vertical-align: top;">
                      <div style="font-family: 'Times New Roman';">By:</div>
                    </td>
                    <td colspan="2" style="vertical-align: top;">
                      <div style="font-family: 'Times New Roman';">/s/ Rohith Adavikolanu <br>
                      </div>
                    </td>
                    <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                    <td style="width: 4.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                      <div style="font-family: 'Times New Roman';">Name:</div>
                    </td>
                    <td style="width: 34.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                      <div style="font-family: 'Times New Roman';"> </div>
                      Rohith Adavikolanu<br>
                    </td>
                    <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                    <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                    <td style="width: 4.45%; vertical-align: top;">
                      <div style="font-family: 'Times New Roman';">Title:</div>
                    </td>
                    <td style="width: 34.39%; vertical-align: top;">
                      <div style="font-family: 'Times New Roman';"> </div>
                      Director<br>
                    </td>
                    <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                  </tr>

              </table>
              <div><br>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div><br>
    </div>
    <br>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">[Signature Page to Underwriting Agreement]</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>The foregoing Agreement is hereby confirmed and accepted as of the date hereof.</div>
    <div><br>
    </div>
    <div>
      <div>
        <div>
          <div>
            <div><br>
            </div>
            <div>
              <div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                      <td colspan="4" style="vertical-align: top; font-family: 'Times New Roman';">
                        <div>
                          <div>DEUTSCHE BANK SECURITIES INC.</div>
                        </div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td colspan="4" style="vertical-align: top;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td colspan="4" style="vertical-align: top; font-family: 'Times New Roman';" rowspan="1">
                        <div>For itself and on behalf of the<br>
                          several Underwriters listed<br>
                          in Schedule I hereto.</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                      <td colspan="4" style="vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;">
                        <div style="font-family: 'Times New Roman';"><br>
                        </div>
                      </td>
                      <td style="width: 3.36%; vertical-align: top;">
                        <div style="font-family: 'Times New Roman';">By:</div>
                      </td>
                      <td colspan="2" style="vertical-align: top;">
                        <div style="font-family: 'Times New Roman';">/s/ Ben Selinger <br>
                        </div>
                      </td>
                      <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                      <td style="width: 4.45%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                        <div style="font-family: 'Times New Roman';">Name:</div>
                      </td>
                      <td style="width: 34.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
                        <div style="font-family: 'Times New Roman';"> </div>
                        Ben Selinger<br>
                      </td>
                      <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top;">&#160;</td>
                      <td style="width: 4.45%; vertical-align: top;">
                        <div style="font-family: 'Times New Roman';">Title:</div>
                      </td>
                      <td style="width: 34.39%; vertical-align: top;">
                        <div style="font-family: 'Times New Roman';"> </div>
                        Director<br>
                      </td>
                      <td style="width: 13.34%; vertical-align: top;">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 4.45%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 34.39%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 13.34%; vertical-align: top;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 4.45%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 34.39%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 13.34%; vertical-align: top;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top; padding-bottom: 2px;" rowspan="1">By: <br>
                      </td>
                      <td style="width: 4.45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">&#160;/s/ Samir Abu-Khadra<br>
                      </td>
                      <td style="width: 13.34%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 4.45%; vertical-align: top;" rowspan="1">Name: <br>
                      </td>
                      <td style="width: 34.39%; vertical-align: top;" rowspan="1">Samir Abu-Khadra <br>
                      </td>
                      <td style="width: 13.34%; vertical-align: top;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 44.37%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 3.36%; vertical-align: top;" rowspan="1">&#160;</td>
                      <td style="width: 4.45%; vertical-align: top;" rowspan="1">Title: <br>
                      </td>
                      <td style="width: 34.39%; vertical-align: top;" rowspan="1">Director <br>
                      </td>
                      <td style="width: 13.34%; vertical-align: top;" rowspan="1">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <br>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">[Signature Page to Underwriting Agreement]</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;"></div>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <font style="font-style: normal;">The foregoing Agreement is hereby confirmed and accepted as of the date hereof.</font><br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3">BNP PARIBAS SECURITIES CORP.<br>
            </td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;" rowspan="1">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3" rowspan="1">&#160;</td>
            <td valign="top" style="width: 13%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;" rowspan="1">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3" rowspan="1">For itself and on behalf of the<br>
              several Underwriters listed<br>
              in Schedule I hereto. <br>
            </td>
            <td valign="top" style="width: 13%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 44%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">/s/ Pierre Lapomme</td>
            <td valign="top" style="width: 13%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 34%;">Pierre Lapomme <br>
            </td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 34%;">Managing Director <br>
            </td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;"> [Signature Page to Underwriting Agreement]<br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;"></div>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;">&#160;</font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> The foregoing Agreement is hereby confirmed and accepted as of the date hereof.</font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"><br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"><br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;">
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3">BOFA SECURITIES, INC.<br>
            </td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;" rowspan="1">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3" rowspan="1">&#160;</td>
            <td valign="top" style="width: 13%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;" rowspan="1">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3" rowspan="1">For itself and on behalf of the<br>
              several Underwriters listed<br>
              in Schedule I hereto. <br>
            </td>
            <td valign="top" style="width: 13%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 44%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">/s/ Christie MacDonald</td>
            <td valign="top" style="width: 13%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 34%;">Christie MacDonald<br>
            </td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 34%;">Managing Director <br>
            </td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 44%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 13%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"><font style="font-style: normal;"></font><br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <font style="font-style: italic;">[Signature Page to Underwriting Agreement]</font>&#160;&#160; </font><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;"></div>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <br>
    </div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"> <font style="font-style: normal;">The foregoing Agreement is hereby confirmed and accepted as of the date hereof.<br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <br>
      </font></div>
    <font style="font-style: normal;"> <br>
    </font>
    <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

        <tr>
          <td valign="top" style="width: 44%;">&#160;</td>
          <td valign="top" style="font-weight: normal;" colspan="3">J.P. MORGAN SECURITIES LLC<br>
          </td>
          <td valign="top" style="width: 13%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 44%;" rowspan="1">&#160;</td>
          <td valign="top" style="font-weight: normal;" colspan="3" rowspan="1">&#160;</td>
          <td valign="top" style="width: 13%;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 44%;" rowspan="1">&#160;</td>
          <td valign="top" style="font-weight: normal;" colspan="3" rowspan="1">For itself and on behalf of the<br>
            several Underwriters listed<br>
            in Schedule I hereto. <br>
          </td>
          <td valign="top" style="width: 13%;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 44%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="top" colspan="2">&#160;</td>
          <td valign="top" style="width: 13%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" align="left" style="width: 44%; padding-bottom: 2px;">
            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
            </div>
          </td>
          <td valign="top" style="width: 3%; padding-bottom: 2px;">
            <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
          </td>
          <td valign="top" nowrap="nowrap" align="left" style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">/s/ Manoj Vemula</td>
          <td valign="top" style="width: 13%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 44%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
          <td valign="bottom" nowrap="nowrap" align="left" style="width: 34%;">Manoj Vemula <br>
          </td>
          <td valign="top" style="width: 13%;">&#160;</td>
        </tr>
        <tr>
          <td valign="top" style="width: 44%;">&#160;</td>
          <td valign="top" style="width: 3%;">&#160;</td>
          <td valign="top" style="width: 4%;">Title:</td>
          <td valign="top" style="width: 34%;">Executive Director <br>
          </td>
          <td valign="top" style="width: 13%;">&#160;</td>
        </tr>

    </table>
  </div>
  <div><font style="font-style: normal;"> </font></div>
  <div><font style="font-style: normal;"><br>
    </font>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <br>
      </font></div>
    <div style="color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;"><font style="font-style: normal;"> <font style="font-style: italic;">[Signature Page to Underwriting Agreement]</font><br>
      </font></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;"> </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">SCHEDULE I</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" id="z724b8046fee0455cad08f64722229c83" style="border-collapse: collapse; width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

          <tr>
            <td style="width: 48%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Underwriters</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Number of Underwritten</div>
              <div style="text-align: center; font-weight: bold;">Shares</div>
              <div style="text-align: center; font-weight: bold;">To Be Purchased</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-weight: bold;">Number of Option</div>
              <div style="text-align: center; font-weight: bold;"> Shares</div>
              <div style="text-align: center; font-weight: bold;">To Be Purchased</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>Goldman Sachs &amp; Co. LLC.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">4,343,221</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">651,483</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>Citigroup Global Markets Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">4,343,221</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">651,483</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>Deutsche Bank Securities Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">4,343,221</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">651,483</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>BNP Paribas Securities Corp.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">2,139,370</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">320,905</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>BofA Securities, Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">2,139,370</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">320,905</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>J.P. Morgan Securities LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">2,139,370</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">320,905</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>Credit Agricole Securities (USA) Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">1,069,685</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">160,452</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>Mizuho Securities USA LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">1,069,685</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">160,452</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>MUFG Securities Americas Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">1,069,685</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">160,452</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>SG Americas Securities, LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">1,069,685</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">160,452</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>BBVA Securities Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">534,842</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">80,226</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>ING Financial Markets LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">534,842</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">80,226</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>UniCredit Capital Markets LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">534,842</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">80,226</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>Santander US Capital Markets LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">534,842</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">80,226</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>Academy Securities, Inc.</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">285,251</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">42,790</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>R. Seelaus &amp; Co., LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">285,251</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">42,790</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div>Siebert Williams Shank &amp; Co., LLC</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">285,250</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">42,789</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%; vertical-align: bottom;">
              <div>Total</div>
            </td>
            <td style="width: 25.52%; vertical-align: bottom;">
              <div style="text-align: right;">26,721,633</div>
            </td>
            <td style="width: 25.5%; vertical-align: bottom;">
              <div style="text-align: right;">4,008,245</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">SCHEDULE II<br>
      Pricing Information</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>Pricing Information Provided by the Underwriters</div>
    <div> <br>
    </div>
    <div style="text-align: justify;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Public Offering Price Per Ordinary Share: $65.25</div>
    <div><br>
    </div>
    <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ordinary Shares: 26,721,633</div>
    <div><br>
    </div>
    <div style="text-align: justify;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Option Shares: 4,008,245</div>
    <div><br>
    </div>
    <div style="text-align: justify;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Repurchase Shares: 7,859,163</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">SCHEDULE III<br>
      <br>
      <br>
      Issuer Free Writing Prospectuses</div>
    <div><br>
    </div>
    <div>None.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">EXHIBIT A</div>
    <div><br>
    </div>
    <div style="text-align: center;">[Form of Lock-Up Agreement]</div>
    <div> <br>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;"></div>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; color: #000000;">Lock-up Agreement</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: right; color: #000000;">November 13, 2023</div>
      <div><br>
      </div>
      <div style="color: #000000;">Goldman Sachs &amp; Co. LLC</div>
      <div style="color: #000000;">200 West Street</div>
      <div style="color: #000000;">New York, New York 10282</div>
      <div><br>
      </div>
      <div style="color: #000000;">Citigroup Global Markets Inc.</div>
      <div style="color: #000000;">388 Greenwich Street</div>
      <div style="color: #000000;">New York, New York 10013</div>
      <div><br>
      </div>
      <div style="color: #000000;">Deutsche Bank Securities Inc.</div>
      <div style="color: #000000;">1 Columbus Circle</div>
      <div style="color: #000000;">New York, New York 10019</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="color: #000000;">As Representatives of the</div>
      <div style="margin-left: 36pt; color: #000000;">several Underwriters listed</div>
      <div style="margin-left: 36pt; color: #000000;">in Schedule I to the</div>
      <div style="margin-left: 36pt; color: #000000;">Underwriting Agreement</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 7.2pt; color: #000000;">Ladies and Gentlemen:</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 7.2pt; margin-left: 7.2pt;"><font style="color: #000000;">The undersigned understands that Goldman Sachs &amp; Co. LLC, Citigroup Global Markets Inc. and </font>Deutsche Bank Securities Inc.<font style="color: #000000;">, as representatives of the several Underwriters (the &#8220;</font><font style="font-weight: bold; color: #000000;">Representatives</font><font style="color: #000000;">&#8221;), propose to enter into an Underwriting Agreement (the &#8220;</font><font style="font-weight: bold; color: #000000;">Underwriting Agreement</font><font style="color: #000000;">&#8221;) with AerCap Holdings N.V., a public limited liability company (</font><font style="font-style: italic; color: #000000;">naamloze vennootschap</font><font style="color: #000000;">) organized under the laws of the Netherlands (the &#8220;</font><font style="font-weight: bold; color: #000000;">Company</font><font style="color: #000000;">&#8221;), and GE Capital US Holdings, Inc., a Delaware corporation and a
          wholly owned subsidiary of the undersigned (the &#8220;</font><font style="font-weight: bold; color: #000000;">Selling Shareholder</font><font style="color: #000000;">&#8221;), providing for the public offering (the &#8220;</font><font style="font-weight: bold; color: #000000;">Public Offering</font><font style="color: #000000;">&#8221;) by the several Underwriters, including the Representatives, of ordinary shares, par value &#8364;0.01 per share, of the Company. Capitalized terms used herein and not otherwise
          defined shall have the meanings set forth in the Underwriting Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 7.2pt; margin-left: 7.2pt; color: #000000;">To induce the Underwriters that may participate in the Public Offering to continue their efforts in connection with the Public Offering, the undersigned General
        Electric Company (&#8220;<font style="font-weight: bold;">GE</font>&#8221;), on behalf of itself and each of its subsidiaries (collectively, the &#8220;<font style="font-weight: bold;">Restricted Parties</font>&#8221;), hereby agrees that, without the prior written
        consent of Goldman Sachs &amp; Co. LLC and Citigroup Global Markets Inc., the Restricted Parties will not, during the period ending 30 days after the date of the Prospectus (the &#8220;<font style="font-weight: bold;">Restricted Period</font>&#8221;): (a)
        offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of (collectively, &#8220;<font style="font-weight: bold;">Transfer</font>&#8221;), directly or indirectly, any shares of any class of stock of the Company</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 7.2pt; color: #000000;">(collectively, the &#8220;<font style="font-weight: bold;">Company Securities</font>&#8221;) or any other securities convertible into or exercisable or exchangeable for any Company Securities (collectively, the &#8220;<font style="font-weight: bold;">Restricted Securities</font>&#8221;); (b) enter into any swap or other arrangement that Transfers to another, in whole or in part, any of the economic consequences of ownership of any Company Securities, whether any such
        transaction described in clause (a) or (b) above is to be settled by delivery of Company Securities or such other securities, in cash or otherwise; (c) file any registration statement with the Commission relating to the offering of any Restricted
        Securities; or (d) publicly announce any intention to engage in any of the transactions described in clauses (a) through (c) above; <font style="font-style: italic;">provided </font>that this clause (d) shall not apply to disclosure by a
        Restricted Party of its general intent with respect to its Company Securities if such disclosure makes no reference to any specific transaction of the type described in clause (a), (b) or (c).</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 7.2pt; margin-left: 7.2pt; color: #000000;">The restrictions contained in the preceding paragraph shall not apply to (a) the sale by the Selling Shareholder of the Securities to be sold pursuant to the
        Underwriting Agreement and the registration of the offer and sale of the Securities under the Securities Act; (b) the sale of Repurchase Shares of the Company by the Selling Shareholder to the Company pursuant to the Underwriting Agreement; (c)
        transactions by a Restricted Party relating to Company Securities or other securities acquired in open market transactions after the completion of the offering of the Securities; <font style="font-style: italic;">provided </font>that any
        Restricted Securities transferred pursuant to clause (d) below shall be deemed to not have been acquired in open market transactions for purposes of this clause (c); (d) Transfers by a Restricted Party of Restricted Securities; <font style="font-style: italic;">provided </font>that (i) each transferee, only to the extent such transferee is not a Restricted Party at the time of such Transfer, shall enter into a written agreement accepting the restrictions set forth herein as
        if it were a Restricted Party and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of a Restricted Party or the Company in connection with any Transfer permitted
        pursuant to this clause (d), it shall include a statement to the effect that the Restricted Securities being Transferred remain subject to the restrictions set forth herein for the remainder of the Restricted Period; (e) Transfers of Restricted
        Securities to the Company or any of its subsidiaries; <font style="font-style: italic;">provided </font>that any Restricted Securities received by the Company or any of its subsidiaries pursuant to such Transfer shall be subject to all of the
        restrictions set forth in Section 5(a)(xii) of the Underwriting Agreement; (f) the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the Transfer of Restricted Securities; <font style="font-style: italic;">provided
        </font>that (i) such plan does not provide for the Transfer of Restricted Securities during the Restricted Period and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on
        behalf of a Restricted Party or the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no Transfer of Restricted Securities may be made under such plan during the Restricted
        Period; or (g) Transfers of Restricted Securities pursuant to a bona fide third party tender offer, merger, consolidation, stock exchange or similar transaction involving a Change of Control (as defined below) of the Company; <font style="font-style: italic;">provided</font> that (i) any such transaction is not solicited by any of the Company, the Restricted Parties or any of their respective affiliates and (ii) in the event that such tender offer, merger, consolidation or
        other such transaction is not completed, the Restricted Parties&#8217; Restricted Securities shall remain subject to the restrictions contained in this agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;). For purposes of clause (g)
        above, &#8220;<font style="font-weight: bold;">Change of Control</font>&#8221; shall mean the consummation of any bona fide third party tender offer, merger, purchase, consolidation or other similar transaction the result of which is that any &#8220;person&#8221; (as
        defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the &#8220;beneficial owner&#8221;</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 7.2pt; color: #000000;">(as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of 50% or more of the total voting power of the voting shares of the Company. In addition, GE, on behalf of itself and each of the other
        Restricted Parties, agrees that, without the prior written consent of Goldman Sachs &amp; Co. LLC and Citigroup Global Markets Inc., the Restricted Parties will not, during the Restricted Period, make any demand for, or exercise any right with
        respect to, the registration of any Restricted Securities if such demand or exercise would result in a public announcement of or public filing (whether of a registration statement with the SEC or any other public filing) with respect to the same
        during the Restricted Period.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 10.8pt; margin-left: 7.2pt; color: #000000;">The undersigned understands that the Company and the Underwriters are relying upon this Agreement in proceeding toward consummation of the Public Offering. The
        undersigned further understands that this Agreement is irrevocable and shall be binding upon the undersigned&#8217;s affiliates, legal representatives, successors and assigns.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 18pt; margin-left: 7.2pt; color: #000000;">Whether or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only be made pursuant to
        an underwriting agreement, the terms of which are subject to negotiation between the Company and the Underwriters.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 21.6pt; margin-left: 7.2pt; color: #000000;">This Agreement shall automatically terminate upon the earlier to occur, if any, of (a) the date of termination of the Underwriting Agreement if such date occurs
        prior to payment for the Ordinary Shares, or (b) November 30, 2023, if the Closing Date has not occurred on or prior to such date.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 18pt; margin-left: 7.2pt; color: #000000;">This Agreement, and any claim, controversy or dispute arising under or related to this Agreement, shall be governed by and construed in accordance with the laws
        of the State of New York, without giving effect to its conflicts of laws principles. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute
        one and the same Agreement. Delivery of an executed counterpart of a signature page to this Agreement by telecopier, facsimile or other electronic transmission (i.e., a &#8220;pdf&#8217; or &#8220;tif&#8217;) shall be effective as delivery of a manually executed
        counterpart thereof. The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic
        signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping
        system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; margin-right: 18pt; margin-left: 7.2pt; color: #000000;">The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any
        action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further
        acknowledges and agrees that, although the Representatives may be required or choose to provide the Selling Shareholder certain Regulation Best Interest and Form CRS disclosures in connection with the Public Offering, the Representatives and the
        other Underwriters are not making a</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="margin-left: 7.2pt; color: #000000;">recommendation to the Selling Shareholder to participate in the Public Offering, enter into this Agreement, or sell any Securities at the price determined in the Public Offering, and nothing set forth
        in such disclosures is intended to suggest that the Representatives or any Underwriters are making such a recommendation.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-style: italic;">[Signature page follows]</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #bfbfbf; background-color: #bfbfbf;"></div>
    </div>
    <div> <br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr>
            <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
            <td valign="top" colspan="3" rowspan="1">Very truly yours, <br>
            </td>
            <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;" rowspan="1">&#160;</td>
            <td valign="top" colspan="3" rowspan="1">&#160;</td>
            <td valign="top" style="width: 12%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="font-weight: normal;" colspan="3">GENERAL ELECTRIC COMPANY, on<br>
              behalf of itself and each of the other<br>
              Restricted Parties<br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
              </div>
            </td>
            <td valign="top" style="width: 3%; padding-bottom: 2px;">
              <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
            </td>
            <td valign="top" nowrap="nowrap" align="left" style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2"><br>
            </td>
            <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 4%;">Name:</td>
            <td valign="bottom" nowrap="nowrap" align="left" style="width: 31%;"><br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" style="width: 4%;">Title:</td>
            <td valign="top" style="width: 31%;"><br>
            </td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>
          <tr>
            <td valign="top" style="width: 50%;">&#160;</td>
            <td valign="top" style="width: 3%;">&#160;</td>
            <td valign="top" colspan="2">&#160;</td>
            <td valign="top" style="width: 12%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div> <br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
  <div class="BRPFPageHeader" style="width: 100%;"></div>
  <div style="font-weight: bold; text-align: right;"><font style="font-family: 'Times New Roman';">Exhibit 99.1</font><br>
  </div>
  <div><br>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zd95672b8765e4338a0d3a6a6b5aa02ed">

        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="color: rgb(10, 40, 95); font-size: 14pt; font-weight: bold;">PRESS RELEASE</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right;"><img height="99" width="231" src="image0.jpg"></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z6ce3c9884eb94dcaa77c8b23cebfeaa8">

        <tr>
          <td style="width: 27.94%; vertical-align: top;">&#160;</td>
          <td style="width: 34.92%; vertical-align: middle;">
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;"><font style="font-weight: bold;">For Investors:</font> Joseph McGinley</div>
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;">Head of Investor Relations</div>
            <div style="text-align: right; font-size: 8pt;"><font style="color: rgb(0, 0, 255);"><u>jmcginley@aercap.com</u></font><font style="color: rgb(10, 40, 95);">; +353 1 418 0428</font></div>
          </td>
          <td style="width: 37.14%; vertical-align: top;">
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;"><font style="font-weight: bold;">For Media:</font> Gillian Culhane</div>
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;">Vice President Corporate Communications</div>
            <div style="text-align: right; font-size: 8pt;"><font style="color: rgb(0, 0, 255);"><u>gculhane@aercap.com</u></font><font style="color: rgb(10, 40, 95);">; +353 1 636 0945</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; color: #0A285F; font-size: 14pt; font-weight: bold;">AerCap Holdings N.V. Announces Secondary Share Offering and Share Repurchase</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #0A285F;">DUBLIN &#8211; November 13, 2023 - AerCap Holdings N.V. (&#8220;AerCap&#8221; or the &#8220;Company&#8221;) (NYSE: AER) today announced that GE Capital US Holdings, Inc. (the &#8220;Selling Shareholder&#8221;), a wholly owned subsidiary of
      General Electric Company, is offering 26,721,633 ordinary shares of AerCap through an underwritten public offering (the &#8220;Secondary Offering&#8221;).&#160; In addition, the Selling Shareholder expects to grant to the underwriters a 30-day option to purchase up
      to 4,008,245 additional ordinary shares from the Selling Shareholder (the &#8220;Option&#8221;).&#160; If the underwriters exercise the Option in full, General Electric Company will cease to beneficially own any of AerCap's ordinary shares. AerCap will not receive
      any proceeds from the sale of the ordinary shares.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #0A285F;">As part of the Secondary Offering, the Company is proposing to purchase approximately $500 million of its ordinary shares from the underwriters at a price per ordinary share equal to the price at which
      the underwriters purchase the ordinary shares from the Selling Shareholder in the Secondary Offering (the &#8220;Share Repurchase&#8221;).&#160; The Company intends to fund the Share Repurchase, which will be consummated pursuant to, and count toward, AerCap&#8217;s
      previously announced share repurchase programs, with cash on hand.&#160; The underwriters will not receive any underwriting discount for the shares purchased by the Company.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #0A285F;">Goldman Sachs &amp; Co. LLC, Citigroup, Deutsche Bank Securities, BNP PARIBAS, BofA Securities and J.P. Morgan are acting as joint bookrunning managers for the Secondary Offering.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #0A285F;">The Company has filed a registration statement (including a prospectus) on Form F-3 with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for the Secondary Offering to which this communication
      relates.&#160; The registration statement automatically became effective upon filing on March 7, 2023.&#160; A preliminary prospectus supplement relating to the Secondary Offering has also been filed with the SEC.&#160; Investors should read the accompanying
      prospectus, dated March 7, 2023, the preliminary prospectus supplement relating to the Secondary Offering, dated November 13, 2023, and documents the Company has filed with the SEC for more complete information about the Company and the Secondary
      Offering.</div>
    <div style="text-align: justify;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"><font style="color: rgb(10, 40, 95);"> <br>
        </font></font></div>
    <div style="text-align: justify;">
      <div style="color: #0A285F;">These documents may be obtained for free by visiting EDGAR on the SEC website at <u>www.sec.gov</u>.&#160; The prospectus supplement and accompanying prospectus relating to the Secondary Offering may also be obtained from:
        Goldman Sachs &amp; Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316, or by emailing <u>prospectus-ny@ny.email.gs.com</u>; Citigroup, c/o Broadridge Financial
        Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-800-831-9146;&#160; Deutsche Bank Securities Inc., Attn: Prospectus Department, at 1 Columbus&#160; Circle, New York, NY 10019, by telephone at 1-800-503-4611 or by email at
        prospectus.cpdg@db.com; BNP Paribas Securities Corp., by email at DL_prospectus_requests@us.bnpparibas.com; BofA Securities, Attention: Prospectus Department, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, or by email at <u>dg.prospectus_requests@bofa.com</u>;
        or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-866-803-9204, or by email at prospectus-eq_fi@jpmchase.com.</div>
      <font style="background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"><font style="color: rgb(10, 40, 95);"> </font></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #0A285F;">This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Company&#8217;s ordinary shares or any other securities, nor shall there be any offer, solicitation or sale
      of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</div>
    <div>&#160;<br>
      <div style="text-align: justify;"> <br>
      </div>
      <div>&#160;</div>
    </div>
    <div>
      <hr align="center" noshade="noshade" style="height: 1px; width: 100%; color: #0A285F; background-color: #0A285F; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageFooter" style="width: 100%;">
        <div>
          <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">AerCap Holdings N.V.</div>
          <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">65 St. Stephen&#8217;s Green, Dublin D02 YX20, Ireland</div>
          <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">www.aercap.com</div>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <br>
    <div style="color: rgb(10, 40, 95); font-weight: bold;">About AerCap</div>
    <div>&#160;</div>
    <div style="color: rgb(10, 40, 95);">AerCap is the global leader in aviation leasing with one of the most attractive order books in the industry. AerCap serves approximately 300 customers around the world with comprehensive fleet solutions. AerCap is
      listed on the New York Stock Exchange (AER) and is based in Dublin with offices in Shannon, Miami, Singapore, Memphis, Amsterdam, Shanghai, Dubai, Seattle, Toulouse and other locations around the world.</div>
    <div>&#160;</div>
    <div style="text-align: justify; color: rgb(10, 40, 95); font-weight: bold;">Forward-Looking Statements</div>
    <div>&#160;</div>
    <div style="text-align: justify; color: rgb(10, 40, 95);">This press release contains certain statements, estimates and forecasts with respect to future performance and events. These statements, estimates and forecasts are &#8220;forward-looking statements&#8221;.
      In some cases, forward-looking statements can be identified by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;aim,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or
      &#8220;continue&#8221; or the negatives thereof or variations thereon or similar terminology. All statements other than statements of historical fact included in this press release are forward-looking statements and are based on various underlying assumptions
      and expectations and are subject to known and unknown risks, uncertainties and assumptions, and may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are
      only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of
      activity, performance or achievements expressed or implied in the forward-looking statements, including, among other things, the availability of capital to us and to our customers and changes in interest rates; the ability of our lessees and
      potential lessees to make lease payments to us; our ability to successfully negotiate flight equipment (which includes aircraft, engines and helicopters) purchases, sales and leases, to collect outstanding amounts due and to repossess flight
      equipment under defaulted leases, and to control costs and expenses; changes in the overall demand for commercial aviation leasing and aviation asset management services; the continued impacts of the Ukraine Conflict, including the resulting
      sanctions by the United States, the European Union, the United Kingdom and other countries, on our business and results of operations, financial condition and cash flows; the rate of recovery in air travel related to the Covid-19 pandemic, the
      aviation industry and global economic conditions; the potential impacts of the pandemic and responsive government actions on our business and results of operations, financial condition and cash flows; the effects of terrorist attacks on the aviation
      industry and on our operations; the economic condition of the global airline and cargo industry and economic and political conditions; development of increased government regulation, including travel restrictions, sanctions, regulation of trade and
      the imposition of import and export controls, tariffs and other trade barriers; the impact of current hostilities in the Middle East, or any escalation thereof, on the aviation industry or our business; a downgrade in any of our credit ratings;
      competitive pressures within the industry; regulatory changes affecting commercial flight equipment operators, flight equipment maintenance, engine standards, accounting standards and taxes.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(10, 40, 95);">As a result, we cannot assure you that the forward-looking statements included in this press release will prove to be accurate or correct. These and other important factors and risks are
      discussed in AerCap&#8217;s annual report on Form 20-F and other filings with the SEC. In light of these risks, uncertainties and assumptions, the future performance or events described in the forward-looking statements in this press release might not
      occur. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. Except as required by
      applicable law, we do not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
    <div style="text-align: justify; color: rgb(10, 40, 95);"> <br>
    </div>
  </div>
  <div class="BRPFPageFooter" style="width: 100%;">
    <div>
      <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">
        <hr align="center" noshade="noshade" style="height: 1px; width: 100%; color: #0A285F; background-color: #0A285F; margin-left: auto; margin-right: auto; border: none;">AerCap Holdings N.V.</div>
      <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">65 St. Stephen&#8217;s Green, Dublin D02 YX20, Ireland</div>
      <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">www.aercap.com</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ex99-2.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cravath, Swaine & Moore LLP
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
  <div style="width: 100%;" class="BRPFPageHeader"></div>
  <div style="font-weight: bold; text-align: right;"><font style="font-family: 'Times New Roman';">Exhibit 99.2</font><br>
  </div>
  <div><br>
    <table cellspacing="0" cellpadding="0" id="zd95672b8765e4338a0d3a6a6b5aa02ed" style="font-family: Arial; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div style="color: rgb(10, 40, 95); font-size: 14pt; font-weight: bold;">PRESS RELEASE</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right;"><img width="231" height="99" src="image0.jpg"></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z6ce3c9884eb94dcaa77c8b23cebfeaa8" style="font-family: Arial; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 27.94%; vertical-align: top;">&#160;</td>
          <td style="width: 34.92%; vertical-align: middle;">
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;"><font style="font-weight: bold;">For Investors:</font> Joseph McGinley</div>
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;">Head of Investor Relations</div>
            <div style="text-align: right; font-size: 8pt;"><font style="color: rgb(0, 0, 255);"><u>jmcginley@aercap.com</u></font><font style="color: rgb(10, 40, 95);">; +353 1 418 0428</font></div>
          </td>
          <td style="width: 37.14%; vertical-align: top;">
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;"><font style="font-weight: bold;">For Media:</font> Gillian Culhane</div>
            <div style="text-align: right; color: rgb(10, 40, 95); font-size: 8pt;">Vice President Corporate Communications</div>
            <div style="text-align: right; font-size: 8pt;"><font style="color: rgb(0, 0, 255);"><u>gculhane@aercap.com</u></font><font style="color: rgb(10, 40, 95);">; +353 1 636 0945</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; color: #0A285F; font-size: 14pt; font-weight: bold;">AerCap Holdings N.V. Announces Pricing of Secondary Share Offering</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #0A285F;">DUBLIN &#8211; November 14, 2023 - AerCap Holdings N.V. (&#8220;AerCap&#8221; or the &#8220;Company&#8221;) (NYSE: AER) today announced the pricing of a secondary offering of 26,721,633 of its ordinary shares (the &#8220;Secondary
        Offering&#8221;) by GE Capital US Holdings, Inc. (the &#8220;Selling Shareholder&#8221;), a wholly owned subsidiary of General Electric Company, at a price to the public of $65.25 per ordinary share. In addition, the Selling Shareholder has granted to the
        underwriters a 30&#8209;day option to purchase up to 4,008,245 additional ordinary shares from the Selling Shareholder (the &#8220;Option&#8221;).&#160; If the underwriters exercise the Option in full, General Electric Company will cease to beneficially own any of
        AerCap's ordinary shares. AerCap will not receive any proceeds from the sale of the ordinary shares.&#160; As part of the Secondary Offering, AerCap will repurchase 7,859,163 of its ordinary shares from the underwriters at a price per ordinary share
        equal to $63.62.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #0A285F;">
        <div><font style="color: #0A285F;">Goldman Sachs &amp; Co. LLC, Citigroup, Deutsche Bank Securities, BNP PARIBAS, BofA Securities, J.P. Morgan, Credit Agricole CIB, Mizuho, MUFG and SOCIETE GENERALE are acting as joint bookrunning managers for the Secondary Offering. BBVA, ING, UniCredit Capital Markets,
            Santander,</font>&#160;<font style="color: #0A285F;">Academy Securities, R. Seelaus &amp; Co., LLC and Siebert Williams Shank are acting as co-managers
            for the Secondary Offering.</font></div>
      </div>
      <div style="text-align: justify; color: #0A285F;"> </div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #0A285F;">The Company has filed a registration statement (including a prospectus) on Form F-3 with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for the Secondary Offering to which this communication
        relates.&#160; The registration statement automatically became effective upon filing on March 7, 2023.&#160; Investors should read the accompanying prospectus, dated March 7, 2023, the preliminary prospectus supplement relating to the Secondary Offering,
        dated November 13, 2023, and documents the Company has filed with the SEC for more complete information about the Company and the Secondary Offering.</div>
      <div style="text-align: justify; color: #0A285F;"> <br>
      </div>
      <div></div>
      <div style="text-align: justify;">
        <div><font style="color: #0A285F;">These documents may be obtained for free by visiting EDGAR on the SEC website at </font><font style="color: #0000FF;"><u>www.sec.gov</u></font><font style="color: #0A285F;">.&#160; The accompanying prospectus and prospectus supplement relating to the Secondary Offering
            may also be obtained from: Goldman Sachs &amp; Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316, or by emailing </font><font style="color: #0000FF;"><u>prospectus-ny@ny.email.gs.com</u></font><font style="color: #0A285F;">; Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by
            telephone at 1-800-831-9146;&#160; Deutsche Bank Securities Inc., Attn: Prospectus Department, at 1 Columbus&#160; Circle, New York, NY 10019, by telephone at 1-800-503-4611 or by
            email at prospectus.cpdg@db.com; BNP Paribas Securities Corp., by email at </font><font style="color: #0000FF;"><u>DL_prospectus_requests@us.bnpparibas.com</u></font><font style="color: #0A285F;">; BofA Securities, Attention: Prospectus Department, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, or by email at dg.prospectus_requests@bofa.com; or J.P. Morgan Securities LLC, c/o
            Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-866-803-9204, or by email at prospectus-eq_fi@jpmchase.com.</font></div>
      </div>
      <div style="text-align: justify;"><font style="color: rgb(10, 40, 95);"> <br>
        </font></div>
      <div style="text-align: justify; color: #0A285F;">This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Company&#8217;s ordinary shares or any other securities, nor shall there be any offer, solicitation or
        sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</div>
      <div><br>
      </div>
      <div>&#160;</div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 1px; width: 100%; color: #0A285F; background-color: #0A285F; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">AerCap Holdings N.V.</div>
          <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">65 St. Stephen&#8217;s Green, Dublin D02 YX20, Ireland</div>
          <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">www.aercap.com</div>
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #BFBFBF; background-color: #BFBFBF; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    &#160;
    <div style="color: rgb(10, 40, 95); font-weight: bold;">About AerCap</div>
    <div>&#160;</div>
    <div style="color: rgb(10, 40, 95);">AerCap is the global leader in aviation leasing with one of the most attractive order books in the industry. AerCap serves approximately 300 customers around the world with comprehensive fleet solutions. AerCap is
      listed on the New York Stock Exchange (AER) and is based in Dublin with offices in Shannon, Miami, Singapore, Memphis, Amsterdam, Shanghai, Dubai, Seattle, Toulouse and other locations around the world.</div>
    <div>&#160; <br>
    </div>
    <div style="text-align: justify; color: rgb(10, 40, 95); font-weight: bold;">Forward-Looking Statements</div>
    <div>&#160;</div>
    <div style="text-align: justify; color: rgb(10, 40, 95);">This press release contains certain statements, estimates and forecasts with respect to future performance and events. These statements, estimates and forecasts are &#8220;forward-looking statements&#8221;.
      In some cases, forward-looking statements can be identified by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;aim,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or
      &#8220;continue&#8221; or the negatives thereof or variations thereon or similar terminology. All statements other than statements of historical fact included in this press release are forward-looking statements and are based on various underlying assumptions
      and expectations and are subject to known and unknown risks, uncertainties and assumptions, and may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are
      only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of
      activity, performance or achievements expressed or implied in the forward-looking statements, including, among other things, the availability of capital to us and to our customers and changes in interest rates; the ability of our lessees and
      potential lessees to make lease payments to us; our ability to successfully negotiate flight equipment (which includes aircraft, engines and helicopters) purchases, sales and leases, to collect outstanding amounts due and to repossess flight
      equipment under defaulted leases, and to control costs and expenses; changes in the overall demand for commercial aviation leasing and aviation asset management services; the continued impacts of the Ukraine Conflict, including the resulting
      sanctions by the United States, the European Union, the United Kingdom and other countries, on our business and results of operations, financial condition and cash flows; the rate of recovery in air travel related to the Covid-19 pandemic, the
      aviation industry and global economic conditions; the potential impacts of the pandemic and responsive government actions on our business and results of operations, financial condition and cash flows; the effects of terrorist attacks on the aviation
      industry and on our operations; the economic condition of the global airline and cargo industry and economic and political conditions; development of increased government regulation, including travel restrictions, sanctions, regulation of trade and
      the imposition of import and export controls, tariffs and other trade barriers; the impact of current hostilities in the Middle East, or any escalation thereof, on the aviation industry or our business; a downgrade in any of our credit ratings;
      competitive pressures within the industry; regulatory changes affecting commercial flight equipment operators, flight equipment maintenance, engine standards, accounting standards and taxes.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: rgb(10, 40, 95);">As a result, we cannot assure you that the forward-looking statements included in this press release will prove to be accurate or correct. These and other important factors and risks are
      discussed in AerCap&#8217;s annual report on Form 20-F and other filings with the SEC. In light of these risks, uncertainties and assumptions, the future performance or events described in the forward-looking statements in this press release might not
      occur. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. Except as required by
      applicable law, we do not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
    <div style="text-align: justify; color: rgb(10, 40, 95);"> <br>
    </div>
  </div>
  <div style="width: 100%;" class="BRPFPageFooter">
    <div>
      <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">
        <hr noshade="noshade" align="center" style="height: 1px; width: 100%; color: #0A285F; background-color: #0A285F; margin-left: auto; margin-right: auto; border: none;">AerCap Holdings N.V.</div>
      <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">65 St. Stephen&#8217;s Green, Dublin D02 YX20, Ireland</div>
      <div style="text-align: center; color: #0A285F; font-family: 'Times New Roman'; font-size: 8pt;">www.aercap.com</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "; 6D# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGH?_ %QE_P#0EKHPO\5&5;X&>Q^'O^1:TK_KSA_] %:59OA[_D6M*_Z\X?\
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M"^3_ !J?JL_(?MHGT!4%[_QX7'_7)OY&N/\ AKXCU[Q'I=[/K]J+>:*8)&!
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M:EW/HB[_ ./*?_KFW\J\%^ ?_(TZG_UY?^SK7O5W_P >4_\ US;^5>"? /\
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M:=(T36[S3'TV[F>UE,321LNTD=<<^M=5X,\7V_C/29=1MK2:VCCF,.V4@EB
M#D8^M?)DDDMU</+(S232N69CR68GD_7-?5/P_P!$/A3P'9V]Y^ZF"-<W.[^
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M-J'[QR?;(_&NCHK!U92ES,T4$E9'S=IWP7\5/J5JM]:PQVAE7SG%PA*IGYB
M#G.,U]'QQI%&L<:A40!54= !TIU%.K6E4MS"A!0V"L?Q5HJ^(O"^HZ40-UQ"
M1&3T#CE3_P!] 5L45FFT[HMJZL?-$'P@\<6UQ'/#9PK)$X=&%RF00<@]:]N\
M6:9JGB#X>7=@ENBZG<V\8:'S!M#Y4L-W3L:ZFBMIUY3:;Z&<::BFEU/FFV^#
MOC.*ZBD:Q@VJX)_TE/7ZU]+445-6M*I;F'""AL%%%%9%A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
-44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
